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Abstract 
 
Yersinia pestis (Y. pestis), as the causative agent of plague, has caused deaths estimated to more 
than 200 million people in three historical plague pandemics, including the infamous Black Death 
in medieval Europe. Although infection with Yersinia pestis can mostly be limited by antibiotics 
and only 2000-5000 cases are observed worldwide each year, this bacterium is still a concern for 
bioterrorism and recognized as a category A select agent by the Centers for Disease Control and 
Prevention (CDC). The investigation into the host-pathogen interactions during Y. pestis infection 
is important to advance and broaden our knowledge about plague pathogenesis for the 
development of better vaccines and treatments.  
 
Y. pestis is an expert at evading innate immune surveillance through multiple strategies, several 
mediated by its type three secretion system (T3SS). It is known that the bacterium induces rapid 
and robust cell death in host macrophages and dendritic cells. Although the T3SS effector YopJ 
has been determined to be the factor inducing cytotoxicity, the specific host cellular pathways 
which are targeted by YopJ and responsible for cell death remain poorly defined. This thesis 
research has established the critical roles of caspase-8 and RIP kinases in Y. pestis-induced 
macrophage cell death. Y. pestis-induced cytotoxicity is completely inhibited in RIP1-/- or RIP3-/-
caspase-8-/- macrophages or by specific chemical inhibitors. Strikingly, this work also indicates 
that macrophages deficient in either RIP1, or caspase-8 and RIP3, have significantly reduced 
infection-induced production of IL-1β, IL-18, TNFα and IL-6 cytokines; impaired activation of 
NF-κB signaling pathway and greatly compromised caspase-1 processing; all of which are critical 
for innate immune responses and contribute to fight against pathogen infection. Y. pestis infection 
causes severe and often rapid fatal disease before the development of adaptive immunity to the 
V 
 
bacterium, thus the innate immune responses are critical to control Y. pestis infection. Our group 
has previously established the important roles of key molecules of the innate immune system: 
TLR4, MyD88, NLRP12, NLRP3, IL-18 and IL-1β, in host responses against Y. pestis and 
attenuated strains. Yersinia has proven to be a good model for evaluating the innate immune 
responses during bacterial infection. Using this model, the role of caspase-8 and RIP3 in 
counteracting bacterial infection has been determined in this thesis work. Mice deficient in 
caspase-8 and RIP3 are very susceptible to Y. pestis infection and display reduced levels of pro-
inflammatory cytokines in spleen and serum, and decreased myeloid cell death. Thus, both in 
vitro and in vivo results indicate that caspase-8 and RIP kinases are key regulators of macrophage 
cell death, NF-κB and caspase-1 activation in Yersinia infection. This thesis work defines novel 
roles for caspase-8 and RIP kinases as the central components in innate immune responses against 
Y. pestis infection, and provides further insights to the host-pathogen interaction during bacterial 
challenge. 
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CHAPTER I: Introduction 
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Innate Immune response 
The host innate immune system is the first protective line of defense against invading pathogens. 
Upon pathogenic organism infection, the host instantly initiates various innate immune responses 
to restrict the pathogen growth as well as guide the adaptive immune system. These innate 
responses include phagocytosis, microbial killing, and the synthesis of pro-inflammatory 
cytokines and chemokines that induce inflammation and recruit other immune cells. Pattern 
recognition receptors (PRRs), which are germ-line encoded, constitute important innate immunity 
components. PRRs sense extracellular or intracellular microorganisms through recognizing 
conserved pathogen-associated molecular patterns (PAMPs) and danger-associated molecular 
patterns (DAMPs) (Janeway and Medzhitov, 2002; Kawai and Akira, 2010). Once activated, 
PRRs initiate an intracellular signaling cascade, culminating in the activation of the nuclear 
factor-κB (NF-κB), MAP kinases (MAPK) and interferon regulatory factor (IRF) families of 
transcription factors, which are responsible for the production of immunomodulatory cytokines, 
chemokines or interferons (Janeway and Medzhitov, 2002; Kawai and Akira, 2010).  Beyond the 
classical innate immune responses mentioned above, growing evidence implicates that pathogen 
infection-induced host cell death emerges as another mechanism with particular impact on the 
innate immune system. Apoptosis, necrosis as well as pyroptosis constitute three distinct modes 
of cell death, and all of them are closely involved in the host immune response to microbial 
infection (Ashida et al., 2011; Lamkanfi and Dixit, 2010). 
 
Toll-like receptors 
Pattern recognition receptors (PRRs) are a large group of extracellular and intracellular receptors 
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that recognize unique PAMPs and DAMPs.  PAMPs are molecular patterns specific to pathogens, 
while DAMPs are endogenous molecules released from damaged cells. PRRs include Toll-like 
receptors (TLRs), NOD-like receptors (NLRs), Retinoic acid-inducible gene (RIG)-I-like 
receptors (RLRs), C-type lectin receptors (CLRs) and AIM2-like receptors (Kawai and Akira, 
2010; Takeuchi and Akira, 2010). Among them, the TLR family is one of the best-characterized 
PRR families. The TLRs are type I integral membrane receptors, which are composed of N-
terminal leucine-rich repeats (LRRs), a transmembrane helix region and a C-terminal cytoplasmic 
Toll-interleukin receptor (TIR) domain (Bell et al., 2003; Kumar et al., 2011). The horseshoe-
shaped LRR domains are responsible for recognizing TLR-specific ligands. The binding of the 
TLR ligands result in dimerization of the LRR domains, which bring the TLRs’ transmembrane 
and cytoplasmic TIR domains in close proximity and trigger a downstream signaling cascade by 
recruiting the adaptor proteins. There are five adaptors downstream of TLRs, including MyD88 
(myeloid differentiation factor 88) (Medzhitov et al., 1998; Muzio, 1997; Wesche et al., 1997), 
Mal (MyD88 adaptor like protein, also called TIRAP) (Fitzgerald et al., 2001), TRIF (TIR 
domain containing adaptor inducing interferon-β) (Yamamoto et al., 2003a), TRAM (TRIF 
related adaptor protein) (Fitzgerald et al., 2003; Hoebe et al., 2003; Yamamoto et al., 2003b),  and 
SARM (sterile-α and HEAT/Armadillo motifs-containing protein) (Carty et al., 2006) . 
 
 Currently, there are 12 TLRs identified in mice and 10 in humans. TLR1 to TLR9 are conserved 
in both species. Mouse TLR10 is a pseudogene and not functional. TLR11, TLR12 and TLR13 
have been lost from the human genome (Kawai and Akira, 2010). Different TLRs sense different 
conserved molecular patterns of microorganisms and self-components. These TLRs can be 
largely divided into two categories based on their cellular locations, TLR1, 2, 4, 5, and 6 are 
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expressed and located on the cell plasma membrane and recognize pathogen membrane 
components like lipids, lipoproteins and proteins. TLR3, 7, 8, 9, 11 and 13 are expressed in 
intracellular endosomal compartments and largely recognize nucleic acids (Kawai and Akira, 
2011).  Specifically, TLR2 interacts with either TLR1 or TLR6 to recognize various PAMPs from 
bacteria, mycoplasma, fungi, and viruses, including bacterial lipopeptides and peptidoglycan, 
zymosan from fungi, etc (Takeuchi and Akira, 2010). Typical ligands for the TLR2-TLR1 
heterodimer are triacylated lipopeptides (Pam3Cys4) from Gram-negative bacteria and 
mycoplasma, while diacylated lipopeptides (Pam2Cys4) from Gram-positive bacteria are the 
typical ligands for the TLR2-TLR6 heterodimer (Kawai and Akira, 2010). TLR5 recognizes 
flagellin, a protein component of bacterial flagella. Tlr10 is a pseudogene in mice due to sequence 
gap and multiple retroviral insertion (Hasan et al., 2005). The role of TLR10 in humans is still 
unclear and it remains an orphan receptor without a known agonist or function. Recent studies 
suggest that TLR10 expression can be up-regulated by influenza virus and TLR10 contributes to 
the sensing of influenza viral infection, but the exact ligand for TLR10 is yet to be identified (Lee 
et al., 2014). TLR11 has close homology to TLR5 and is expressed in mice but not in humans. 
TLR11 senses uropathogenic bacteria and, in cooperation with TLR12, binds to a profilin-like 
molecular pattern from the intracellular protozoan Toxoplasma gondii (Yarovinsky et al., 2005). 
TLR13 has been recently identified to recognize bacterial ribosomal RNA (Hidmark et al., 2012; 
Oldenburg et al., 2012). TLR3, 7, 8, 9 are intracellular TLRs and are mainly located in the 
endosomal compartment. While TLR3 is known to recognize dsRNA, TLR7 and 8 sense ssRNA. 
TLR9 detects unmethylated 2’-deoxyribo (cytidine-phosphate-guanosine) CpG motifs, which are 
frequently found in bacteria but rare in vertebrates. To mimic these natural ligands, poly (I:C) (a 
synthetic dsRNA) is often used as a TLR3 ligand, while synthetic CpG DNA is used as a TLR9 
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ligand, and the imidazoquinoline compounds such as R848 as TLR7/TLR8 ligands in 
experiments. 
 
Toll-like receptor 4 (TLR4) 
TLR4 is probably the most extensively characterized toll-like receptor. It recognizes 
lipopolysaccharide (LPS) together with the adaptor myeloid differentiation factor 2 (MD2) 
(Medzhitov et al., 1997; Shimazu et al., 1999). LPS is the major component of Gram-negative 
bacterial cell-wall, and is also known as endotoxin, the agent responsible for septic shock. LPS is 
composed of a lipid A portion anchored in the outer membrane, a polysaccharide core structure 
and an O-antigen (Raetz and Whitfield, 2002). The lipid A of LPS is the part recognized by 
TLR4-MD2 complex. The crystal structure of the TLR4-MD2-LPS complex indicates that two 
TLR4-MD2 complexes interact symmetrically to form a homodimer via the hexa-acyl-chains of 
lipid A, which are embedded in the hydrophobic pocket of MD2 or is hydrophobically bound to 
TLR4 (Park et al., 2009). The dimerization of the TLR4/MD2 complex initiates the signaling 
cascade by recruiting the adaptor proteins to its TIR domains. TLR4 is the only TLR which uses 
all four adaptor proteins (MyD88, Mal, TRIF and TRAM) to mediate its immune signaling 
pathway, and it can be divided into MyD88-dependent and MyD88-independent pathways (Fig 
1.1) (Takeuchi and Akira, 2010; Yamamoto et al., 2003b).  
 
Activation of the MyD88-dependent pathway leads to a fast, robust early activation of NF-κB and 
MAPKs. Upon LPS binding to TLR4/MD2, Mal and MyD88 are recruited to the TIR domain of 
TLR4 at the plasma membrane. Then IRAK (IL-1 receptor-associated kinase) family members 
are engaged to MyD88/Mal. The first recruited and activated one is IRAK4, followed by IRAK1 
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and IRAK2 (Fig. 1.1). TRAF6 (tumor necrosis factor receptor-associate factor 6) subsequently 
interacts with the IRAKs, leading to TRAF6’s phosphorylation and activation. TRAF6 acts as an 
E3 ligase to add K63 (Lys63)-linked polyubiquitin chains to target proteins, including TAK1 
(transforming growth factor-β-activated kinase 1), TAB2, TAB3 and NEMO (IκB kinase (IKK) 
subunit NF-κB essential modifier, also called IKKγ). Activated TAK1 phosphorylates IKKβ, 
which leads to the phosphorylation, ubiquitination and degradation of IκB (inhibitor of κB). IκB 
degradation frees NF-κB and allows it to translocate into nucleus, leading to the transcription of 
pro-inflammatory cytokines and antimicrobial factors (Fig. 1.1). TAK1 also activates the MAPKs, 
including ERK, p38 and JNK, which trigger the signal transduction, resulting in the activation of 
transcription factors, like AP-1 (Takeuchi and Akira, 2010) (Fig. 1.1). MyD88 is required by all 
of the TLRs (except TLR3) to implement their effects. TLR3, however, utilizes MyD88-
independent TRIF-dependent pathway to realize its pro-inflammatory effects. The TRIF/TRAM–
dependent pathway acts as the other arm of signaling downstream of TLR4, mediating the 
activation of late phase NF-κB and IRF pathways.  After initiation of MyD88-mediated pathway, 
TLR4 moves from the plasma membrane to the endosomes and activates the TRIF/TRAM-
dependent pathway (Fig. 1.1) (Kawai and Akira, 2010). At the endosome, TRIF and TRAM are 
recruited to the TIR domain of TLR4. Subsequently, TRIF recruits RIP1 (Receptor interacting 
protein 1) through its RHIM (RIP homotypic interaction motif) domain, as well as TRAF6 and 
TRADD, leading to the activation of TAK1, which in turn activates the NF-κB pathway. 
Additionally, TRIF also recruits and activates TRAF3, which causes the formation of a signaling 
complex composed of the noncanonical IKKs TBK1 and IKKε (also called IKK-і). TBK1 and 
IKKε then catalyze the phosphorylation of IRF3 and allow its nuclear transclocation, leading to 
the transcription and production of Type I interferons (IFNα and IFNβ) (Fig. 1.1) (Kawai and 
Akira, 2010; Takeuchi and Akira, 2010).  
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Takeuchi and Akira, Cell. 2010 Mar 19;140(6):805-20. 
Figure 1.1 Schematic representation of TLR4, TLR2 and TLR3 signaling pathways 
LPS recognized by TLR4/MD2 initiates both MyD88-dependent and MyD88-independent 
pathways. dsRNA recognized by TLR3 only initiates TRIF-mediated pathway while lipoprotein 
by TLR1/6 and TLR2 leads to MyD88-dependent pathway. MyD88 and Mal are recruited to the 
TLR, and subsequently IRAKs and TRAF6 are also recruited. TRAF6, together with an E2 
ubiquitin ligase complex of Ubc13 and Uev1A, catalyze a K63-linked polyubiquitin chain on 
TRAF6 itself and the TAK1-TAB2/3 complex, which leads to the activation of NF-κB and 
MAPK pathways. At the endosome, TRAF6, RIP1 and TRAF3 are recruited to TRIF to activate 
NF-κB and IRF3 signaling. NAP1 and SINTBAD are required for the activation of TBK1/IKK-і, 
which phosphorylate IRF3 (Takeuchi and Akira, 2010). 
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Inflammasome 
The inflammasomes are a group of multiprotein complexes that mediate the activation of 
inflammatory caspases, especially caspase-1, leading to the maturation of cytokine IL-1β and IL-
18 and the occurrence of pyroptosis (Vladimer et al., 2013). The key components of 
inflammasome complexes are NOD-like receptors (NLRs), which belong to another family of  
PRRs and play important roles in host defense. The NLRs are a large family of cytosolic sensors, 
with 23 members in humans and 34 members in mice (Bryant and Fitzgerald, 2009). NLRs share 
a common tripartite structure, comprised of a C-terminal leucine-rich repeat (LRR) domain, a 
central NACHT/NOD domain (nucleotide-binding oligomerization domain), and a variable N-
terminal domain (Bryant and Fitzgerald, 2009). The LRR domain is probably involved in directly 
or indirectly recognizing PAMPs or DAMPs. The variable N-terminal domain, which mediates 
protein-protein interaction, can be either a caspase recruitment and activation domain (CARD), a 
Pyrin domain (PYD), or a baculovirus inhibitor of apoptosis repeat domain (BIR) (Bryant and 
Fitzgerald, 2009). The NLR members that constitute inflammasome complexes share an N-
terminal PYD domain or an N-terminal CARD domain, and are thereby referred as NLRP or 
NLRC respectively, including NLRP1, NLRP3, NLRP6, NLRP12, and NLRC4 (IPAF).  Another 
inflammasome complex does not contain any NLRs, but instead contains a HIN200 family 
protein, AIM2 (Absent in melanoma 2), which consists of a HIN200 and a PYD domain (Bryant 
and Fitzgerald, 2009; Vladimer et al., 2013).  
 
The inflammasomes can be activated by a wide range of different stimuli, including diverse 
microbial, environmental, or endogenous danger signals. Upon stimulation, the components of 
inflammasome start to assemble through oligomerization, and recruit pro-caspase-1 directly via a 
CARD homotypic interaction (e.g., NLRP1 or NLRC4 inflammasomes) or indirectly by the help 
of the adaptor ASC (apoptosis-associated speck-like protein containing a CARD), which interacts 
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with NLRs through PYD domains (e.g., NLRP3 or AIM2 inflammasomes) (Stutz et al., 2009). 
The exact mechanism underlying inflammasome formation and activation is still not well 
understood. Once the pro-caspase-1 is recruited to inflammasome complex, these pro-enzymes 
undergo auto-cleavage induced by the proximity of two or more caspase-1 monomers, leading to 
the cleavage of the pro-enzyme into 20-kDa (p20) and 10-kDa (p10) subunits (Stutz et al., 2009).  
Active caspase-1, acting as a heterodimer of p20 and p10 subunits, then proteolytically cleaves 
pro-IL-1β and pro-IL-18, enabling the release of mature IL-1β and IL-18 cytokines. Mature IL-1β 
is a potent pyrogen with multiple pleiotropic functions, including promoting the development and 
differentiation of T, B, and hematopoietic cells, initiating the acute phase responses and 
participating in cell proliferation and apoptosis. Due to its highly potent pro-inflammatory 
activities, the synthesis, processing and release of IL-1β are tightly regulated, requiring two 
separate signals and processes. First, “signal 1”, frequently initiated by different PRRs (like the 
TLRs), induces NF-κB and MAPK activation, which results in the transcription and production of 
pro-IL-1β. With pro-IL-1β in the cytosol, other stimuli induce “signal 2” which leads to the 
processing of these pro-IL-1β into mature cytokines through caspase-1-mediated proteolysis. 
These two distinct processes ensure the safety of producing and releasing mature IL-1β (Bryant 
and Fitzgerald, 2009; Vladimer et al., 2013). 
 
Although caspase-1 is defined as the canonical caspase activated by the inflammasomes to 
mediate IL-1β and IL-18 maturation, recent studies have shown that other non-canonical caspases, 
including caspase-11 and caspase-8, are also involved.  Firstly, Kayagaki et al. indicated that 
caspase-11 is critical for caspase-1 activation and IL-1β production in macrophages infected with 
E. coli, Citrobacter rodentium or Vibrio cholerae (Kayagaki et al., 2011). More importantly and 
surprisingly, they also showed that the existing Caspase 1-/- mice that were routinely being used 
at that time, also lack caspase-11 as a result of backcrossing a passenger mutation from the 
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caspase-11-deficient 129 mouse strain into C57BL/6 mice. Thus, these mice were functionally 
caspase-1/caspase-11 double knockouts (Kayagaki et al., 2011). Through using caspase-1 or 
caspase-11 single knockout macrophages, they found that caspase-11 triggers pyroptosis 
independently of caspase-1. However, for IL-1β release, caspase-11 is proposed to cooperate with 
NLRP3, ASC and caspase-1 to trigger non-canonical inflammasome activation (Kayagaki et al., 
2011).  Subsequent studies by both Rathinam et al. and Broz et al. demonstrated that TLR4-TRIF 
activates caspase-11 via type I IFN signaling during infection with Gram-negative bacteria, 
including enterohemorrhagic E. coli (EHEC), Citrobacter rodentium and Salmonella 
typhimurium (Broz et al., 2012; Rathinam et al., 2012). Activated caspase-11 synergizes with 
NLRP3 inflammasome to regulate caspase-1 activation and IL-1β release, and simultaneously 
leads to caspase-1-independent cell death (Rathinam et al., 2012). These results suggest that 
caspase-11 orchestrates both capsase-1-dependent and -independent effects, possibly through 
distinct mechanisms.  
 
Caspase-8 is an important initiator caspase in apoptosis (will be described later in this thesis). 
However, recent investigations have indicated that caspase-8 can also induce IL-1β and IL-18 
cleavage independent of caspase-1 when stimulated with TLR ligands, poly(I:C) and LPS 
(Maelfait et al., 2008), death-inducing receptor Fas ligand (FasL) (Bossaller et al., 2012), or fungi 
and mycobacteria sensed by a C-type lectin receptor dectin-1 (Gringhuis et al., 2012). In these 
studies, caspase-8-mediated IL-1β maturation does not require any known NLRs, although ASC 
may be required. In addition, caspase-8 deficiency in dendritic cells facilitates LPS-induced 
activation of the NLRP3 inflammasome and IL-1β secretion. This effect is dependent on RIP1, 
RIP3, MLKL and PGAM5, all of which are involved in programmed necrosis (Kang et al., 2013), 
which will be described in more detail later in this thesis. Paradoxically, TLR priming plus IAP 
(inhibitor of apoptosis) protein inhibition triggers the maturation and secretion of IL-1β that is 
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mediated not only by the NLRP3-caspase-1 inflammasome, but also by the caspase-8 non-
canonical inflammasome. Interestingly, both NLRP3-caspase-1 and caspase-8 inflammasomes 
require RIP3 and ROS production (Vince et al., 2012). These controversial results suggest that 
caspase-8 can regulate IL-1β activation by two different mechanisms. Active caspase-8 can 
directly cleave IL-1β via a caspase-1-independent pathway, while caspase-8 protein can block 
RIP3-mediated inflammasome activation and IL-1β secretion. Caspase-8 deficiency triggers the 
disruption of cell homeostasis and leads to a failure in blocking RIP3-mediated activation of the 
NLRP3 inflammasome (Wen et al., 2013).  
 
Host cell death 
Cell death is important to maintain tissue homeostasis in multicellular organisms. When 
encountering pathogen invasion, host cell death is elicited as an intrinsic innate immune defense 
mechanism. Cell death plays a critical role in host-pathogen interactions. However, the exact 
function seems to be context-dependent. On one hand, inducing immune cell death can eliminate 
the replication niche of intracellular bacteria, thus inhibiting the proliferation of these pathogens 
and exposing them to bactericidal mechanisms. On the other hand, elimination of key immune 
cells can diminish the ability of those cells to respond to infection, enable bacteria to evade the 
host immune defenses, and prompt the dissemination of bacteria in the host. Thus, eliciting host 
cell death is a double-edged sword with either protective or harmful outcomes in terms of 
controlling infection (Ashida et al., 2011; Lamkanfi and Dixit, 2010). Apoptosis, necrosis and 
pyroptosis represent the three major modules of cell death during infection. The mechanisms of 
the three cell death modules are different and complicated. The choice of death mode is also 
complex, dependent on different factors, ranging from the nature of the microbial infection, the 
site of infection and the stage of infection. Pathogens are also equipped with different effectors 
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and toxins that may target the host cell death machinery and manipulate different signaling 
pathways leading to host cell death (Ashida et al., 2011; Lamkanfi and Dixit, 2010). 
 
Apoptosis 
Apoptosis is the best characterized mode of programmed cell death. The term “Apoptosis” 
derives from Greek language and means the leaves “falling off” from trees in autumn. It was first 
used in 1972 by Kerr et al. (Kerr et al., 1972). Apoptosis is crucial for embryonic development, 
tissue homeostasis and other physiological processes, as well as a number of pathological 
diseases, such as cancer, autoimmune disorders and pathogen infections. Apoptotic cells display 
distinct morphologies with membrane blebbing, cell shrinkage, chromatin condensation, DNA 
fragmentation and the formation of apoptotic bodies (Strasser et al., 2000). Normally, apoptotic 
cell death is triggered by two different pathways: the extrinsic or death receptor pathway and 
intrinsic or mitochondrial pathway. Both pathways converge on the activation of the cascade of 
cysteinyl aspartate-specific proteases (caspases) (Thornberry, 1998). Different initiator caspases 
(caspase-2, 8, 9, or 10) are activated by either extrinsic or intrinsic stimuli, and then the 
executioner caspases (caspase-3, 6, 7) are directly cleaved and activated by respective initiator 
caspases. Activated executioner caspases then cleave several substrates, such as poly-ADP ribose 
polymerase-1 (PARP-1), the inhibitor of caspase-activated DNase (ICAD) and so on, ultimately 
leading to the occurrence of apoptosis (Strasser et al., 2000; Thornberry, 1998). 
 
The extrinsic pathway is initiated by binding of extracellular ligands to their corresponding 
transmembrane receptors which are called death receptors. Such ligands belong to the tumor 
necrosis factor (TNF) superfamily, including TNFα, Fas ligand (FasL) and TNF-related 
apoptosis-inducing ligand (TRAIL). Upon ligands ligation, specific cytoplasmic adaptors, such as 
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FADD, RIP1 or TRADD, are recruited to the death receptors to form a death-inducing signaling 
complex (DISC) (Boatright et al., 2003; Daniel, 2000). FADD then recruits monomeric pro-
caspase-8 to the DISC complex through death effector domain (DED) interactions. DISC 
formation subsequently facilitates the dimerization of pro-caspase-8, which results in its 
activation and auto-proteolytic cleavage (Fuentes-Prior and Salvesen, 2004; van Raam and 
Salvesen, 2012). Pro-caspase-8 cleaves itself between the DEDs and the large subunit, leading to 
the release of active (cleaved) caspase-8 from the DISC to directly activate the executioner 
caspases (Boatright et al., 2003; Strasser et al., 2000). The interaction between FADD and pro-
caspase-8 can be regulated by cellular FLICE-like inhibitory protein (cFLIP). All cFLIP isoforms, 
including long, short and Raji isoforms, contain DED domains which compete with pro-caspase-8 
to bind to FADD thus prevent the interaction between FADD and pro-caspase-8. cFLIP long 
(cFLIPL) isoform also contains a caspase-like domain in which the active-center cysteine residue 
is substituted by a tyrosine residue. cFLIPL can form heterodimer with caspase-8 to mediate the 
activation and partial self-processing of caspase-8 (Irmler et al., 1997; Yu and Shi, 2008). 
 
The intrinsic apoptosis pathway is induced by different stimuli, including growth-factor depletion, 
DNA damaging agents like UV irradiation and chemotherapeutics, etc. These stimuli induce 
mitochondrial outer membrane permeabilization (MOMP) and the release of cytochrome c, 
SMAC/Diablo and HtrA2/Omi into the cytosol from the mitochondrial intermembrane space 
(Cain et al., 2002; Liu et al., 1996). Released cytochrome c interacts with the adaptor Apoptosis 
protease activationg factor-1 (Apaf-1) to form the apoptosome complex, which serves as a 
scaffold to recruit and activate initiator caspase-9 (Cain et al., 2002). 
 
In addition to its crucial role in various physiological conditions, like embryonic development and 
maintenance of tissue homeostasis, apoptosis also contributes to regulating host-pathogen 
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interactions. Many bacterial pathogens, such as Staphylococcus aureus, Listeria moncytogenes, 
and Yersiniae, can induce host cell apoptosis to destroy the immune protective cells of host and 
thus facilitate their infection. In contrast, some bacteria, including Legionella pneumophila, A. 
phagocytophilum, Chlamydia spp. and others, inhibit macrophage apoptosis to maintain their 
replication niches via different mechanisms (Lamkanfi and Dixit, 2010; Rudel et al., 2010).  
 
Necrosis 
Necrosis was first described as accidental cell death with swelling of organelles, plasma 
membrane rupture and cell lysis. Recent studies have indicated that certain types of necrosis can 
also be tightly regulated, and this has given rise to the new term: necroptosis, which means 
programmed necrosis. The serine-threonine kinase Receptor-interacting protein 1 (RIP1) was the 
first identified regulator of necrosis. It is required for Fas or TNFα-triggered necrosis in Jurkat 
human T lymphocyte cells or mouse embryonic fibroblasts (MEFs) respectively (Holler et al., 
2000). In 2009, three groups identified RIP3, another RIP family member, as a key regulator of 
death receptor-induced necrosis (He et al., 2009; Cho et al., 2009; Zhang et al., 2009). The 
availability of RIP3-/- mice facilitates the study of necrosis in pathophysiology and since then, 
necroptosis and the related molecules have gained intensive investigations. RIP1/RIP3-mediated 
necroptosis has been found to play an important role in various pathophysiological conditions, 
such as microbial infections, Crohn’s diseases, acute pancreatitis, atherosclerosis and other 
inflammation-mediated tissue damages (reviewed by Moriwaki and Chan, 2013). Many stimuli 
can induce necroptosis, including death cytokines of the TNF family, intracellular ATP depletion, 
mitochondrial depolarization, poly-(ADP-ribose) polymerase (PARP) activation, increased 
reactive oxygen species (ROS) and several viruses like vaccinia virus, herpes virus, mouse 
cytomegalovirus (Vanlangenakker et al., 2012). Upon exposure to these stimuli, RIP1 interacts 
15 
 
with RIP3 through their RHIM domains, a hydrophobic patch of β sheet flanked by unstructured 
coiled-like residues. The interaction between RIP1 and RIP3 leads to the assembly of necrosome, 
which shows a filamentous structure with classical characteristics of β-amyloids (Li et al., 2012).  
For the downstream execution of necroptosis, MLKL (mixed-lineage kinase domain-like) and 
mitochondrial protein phosphatase PGAM5 have been recently identified as RIP3 substrates. 
Both MLKL and PGAM5 have been indicated as components of necrosome complex and are 
required for the processing and execution of necrosis (Sun et al., 2012; Wang et al., 2012). 
MLKL can interact with RIP3 through its C-terminal kinase-like domain, which is 
phosphorylated by RIP3 at Thr357 and Ser358 residues, and this interaction between MLKL and 
RIP3 is dependent on the kinase activity of RIP3 (Sun et al., 2012). Knocking down MLKL 
expression or treating cells with human MLKL inhibitor necrosulfonamide, can arrest the 
necrosis induced by TNFα + Smac mimetic + z-VAD-fmk (Sun et al., 2012).  The role of MLKL 
in necroptosis is further confirmed by the generation of Mlkl knockout mice by transcription 
activator-like effector nucleases (TALENs)-mediated gene disruption (Wu et al., 2013). Mlkl 
knockout mice are viable, healthy, fertile and do not show any abnormities in the development of 
T cells, macrophages and neutrophils, similar to RIP3 knockout mice. However, mouse 
embryonic fibroblasts (MEFs) and macrophages from the Mlkl-deficient mice are resistant to 
necrosis induced by LPS plus zVAD, or TNF plus Smac mimetic and zVAD. Moreover, Mlkl 
knockout mice are protected from cerulean-induced acute pancreatitis, which is recognized as a 
necrosis-associated disease and requires RIP3 for disease progression (Wu et al., 2013). A distinct 
Mlkl deficient mouse generated by another group shows similar phenotypes and results, 
confirming that MLKL is required for necroptosis induced by TNFα (Murphy et al., 2013). 
Several very recent studies further clarified the mechanism about how MLKL mediates TNFα-
induced necroptosis (Cai et al., 2014; Chen et al., 2014; Wang et al., 2014). Since Thr357 and 
Ser358 of MLKL are phosphorylated during necroptosis and mutations of these two residues into 
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alanine suppress necrosis progression (Sun et al., 2012), a monoclonal antibody that specifically 
recognizes phosphorylated Thr357/Ser358 of MLKL can be utilized as a specific cellular marker 
to detect necroptosis. Through the development of this monoclonal antibody and using it in a 
series of biochemical assays, Wang et al. (2014) demonstrate that the phosphorylation of MLKL 
induced by RIP3 in necrosis triggers MLKL to form an oligomer, which binds to 
phosphatidylinositol lipids and cardiolipin of membrane compartment. The oligomerization of 
phosphorylated MLKL enables the necrosome to translocate from the cytosol to the plasma and 
intracellular membranes, leading to membrane disruption and necrosis occurrence.  Moreover, the 
antibody against phospho-MLKL is able to detect necroptotic hepatocytes in human liver biopsy 
samples from patients with drug-induced liver injury, a disease that involves necroptosis for the 
disease progression confirmed by RIP3 knockout mice, but not in healthy donor’s liver samples 
(Wang et al., 2014). The results of two other studies support that the oligomerization of MLKL 
and the translocation of the MLKL oligomers to plasma membrane are essential for TNFα-
induced necrosis (Cai et al., 2014; Chen et al., 2014). All these investigations are carried out 
utilizing the necrosis model induced by TNFα, Smac mimetic and zVAD-fmk treatment. Thus, 
the role of MLKL in necrosis needs to be expanded in other models of necrosis stimuli. In 
addition to MLKL, the mitochondrial protein phosphatase PGAM5 has been identified as another 
substrate of RIP3. Upon necrosis induction by TNFα, PGAM5 is recruited to the RIP1-RIP3-
MLKL necrosome complex and PGAM5 subsequently recruits the mitochondrial fission factor 
Drp1 and dephosphorylates it at serine 637, thereby activating Drp1’s GTPase activity. Activated 
Drp1 has been proposed to trigger mitochondrial fragmentation, which is observed in both 
apoptosis and necrosis and is required for necrosis execution (Wang et al., 2012). A subsequent 
study suggested that Drp1 is not required for RIP3-induced necroptosis, through using stable cell 
lines of wild-type, Mlkl-/- and Drp1-/- MEFs that express a 4-hydroxytamoxifen (4HT)-inducible 
RIP3-gyrase construct. In this study, necroptosis of MEFs is triggered by induced expression and 
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forced dimerization of RIP3, instead of using the combinational treatment of TNFα, Smac 
mimetic and zVAD-fmk as previously used by Wang et al. (Moujalled et al., 2014; Wang et al., 
2012). Hence, different stimuli and different cell lines make the context complicated, leading to 
different results and conclusions. These findings suggest that there might be different substrates 
and mechanisms that mediate necrosis execution, in different cell types and by different necrotic 
stimuli. Further studies in various models are needed to elucidate the necrosis execution pathways. 
 
The interplay between RIP1, Caspase-8 and RIP3 in apoptosis, necrosis 
and inflammation 
The necrosis induced by combined TNFα, Smac mimetic and zVAD-fmk treatment is the most 
extensively characterized cellular model of necrosis. Much of our knowledge about the 
mechanism of necroptosis has been achieved by studying this model. However, TNFα can trigger 
three different outcomes based on cellular status and molecular context: NF-κB and MAPK 
pathways activation, apoptosis and necroptosis (Christofferson et al., 2014; Festjens et al., 2007).  
Upon TNFα ligation to its receptor TNFR1, multiple proteins are recruited to TNFR1 at the 
plasma membrane to form the signaling complex termed as ‘complex І’ that consists of TRADD, 
RIP1, cIAP1/2, TRAF2 and TRAF5. As E3 ligases, cIAP1/2 mediate the polyubiquitination of 
RIP1, which provides a docking site to recruit the IKK complex and the TAK1-TAB1-TAB2 
complex, leading to the activation of NF-κB and MAPK pathways. Thus, complex I functions as 
a scaffold to recruit downstream kinases and effector proteins to activate NF-κB and MAPK 
pathways, leading to cell survival and proliferation (Fig. 1.2) (Christofferson and Yuan, 2010; 
Festjens et al., 2007). When RIP1 is deubiquitinated by the deubiquitinase CYLD 
(cyclindromatosis), it translocates from the plasma membrane to cytosol to form a second 
complex (complex IIa). Complex IIa often (but not invariably) contains RIP1, Caspase-8, FADD 
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(Fas-associated protein with a death domain), cFLIP and RIP3 (Ofengeim and Yuan, 2013). In 
complex IIa, caspase-8 is activated and exerts two functions. On one hand, active caspase-8 
initiates the caspase cascade, leading to the fate of apoptotic cell death. On the other hand, 
caspase-8 can also inhibit RIP3-mediated necroptosis, potentially through cleaving RIP1 and 
RIP3 (Chan et al., 2003; Feng et al., 2007). cFLIP and FADD are also required to block 
necroptosis (Dillon et al., 2012). Hence, when caspase-8, FADD or cFLIP are blocked either by 
pharmacological inhibitors or by genetic deficiency, the inhibitory effect on RIP1 and RIP3 is 
abrogated, leading to the formation of another complex (complex IIb). Complex IIb is also called 
necrosome, which is composed of RIP1, RIP3 and MLKL. This complex triggers the necrosis 
induction (Fig. 1.2) (Christofferson et al., 2014; Vandenabeele et al., 2010). Therefore, the cell 
fate after TNFα stimulation is decided by the interplay between RIP1, Caspase-8 and RIP3. 
 
RIP1 and RIP3 belong to the RIP family. Both of them have an active N-terminal kinase domain, 
and a RIP homotypic interaction motif (RHIM) at the C terminus of RIP3, but in the intermediate 
domain of RIP1. RIP1 also has a C-terminal death domain (DD), which mediates the interaction 
between RIP1 and TRADD, Fas and other DD-containing proteins. The RHIM domain mediates 
the interaction between RIP1 and RIP3, and is required for induction of necrosis (Moquin and 
Chan, 2010; Ofengeim and Yuan, 2013). The kinase domain of RIP1 and RIP3 is also critical for 
necrosis. RIP1 kinase activity is required for the interaction of RIP1 with RIP3, and the formation 
of necrosome complex. Necrostatin-1 (Nec-1), a small molecule that allosterically blocks the 
kinase activity of RIP1, can inhibit the induction of necrosis, but leave RIP1-mediated NF-κB and  
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Figure 1.2  Schematic representation of the signaling pathways induced by TNFα. 
Activation of TNFR1 by TNFα leads to three distinct outcomes which are regulated by different 
complexes: the formation of complex I leads to NF-κB activation; complex IIa leads to apoptosis 
and complex IIb to necroptosis (Christofferson et al., 2014). 
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MAPKs activation unaffected (Degterev et al., 2005). Nec-1 treatment abolishes the interaction of 
RIP1 and RIP3, suggesting that the kinase activity of RIP1 is crucial for assembly of the RIP1-
RIP3 necrosome complex (Cho et al., 2009; He et al., 2009).  
 
Caspase-8, as a cysteine protease, is originally recognized as an initiator caspase in extrinsic 
apoptosis pathway induced by the death receptors of TNF superfamily. Later it has been found to 
harbor other non-apoptotic functions as well, including mediating the NF-κB activation in T cells 
and B cells (Kang et al., 2004; Su et al., 2005). The non-apoptotic role of caspase-8 has started to 
be clarified through various transgenic mouse models. Caspase-8 deficient mice are embryonic 
lethal, die between embryonic day 10.5 (E10.5) and E11.5, with extensive necrotic cell death and 
vascular cardiac and hematopoietic defects (Varfolomeev et al., 1998). The additional deficiency 
of RIP3, however, can rescue the embryonic lethality of Casp8-/- mice. Casp8-/-Rip3-/- double 
knockout mice are viable and mature into fertile adults with a full immune complement of 
myeloid and lymphoid cells (Kaiser et al., 2011; Oberst et al., 2011). When getting over the first 
few months of age, these Casp8-/-Rip3-/- mice develop splenomegaly lymphadenopathy, that are 
due to a marked accumulation of B220+, CD3+ T cells in the secondary lymphoid tissues. This 
lymphadenopathy phenotype is similar to Fas-deficient (lpr/lpr) mice which have abnormal 
accumulation of B220+, CD3+, CD4-, CD8- T lymphocytes in the periphery and develop the 
autoimmune lymphoproliferative syndromes (ALPS) (Siegel et al., 2000). Through reconstituting 
Casp8
-/-
Rip3
-/- DKO mouse embryonic fibroblasts (MEF) with caspase-8, non-cleavable caspase-
8DA or catalytically inactive caspase-8CA, it was demonstrated that apoptosis mediated by caspase-
8 depends on cleavage of caspase-8 which is consistent with previous studies, while the inhibitory 
effect on RIP3-mediated necrosis by caspase-8 does not require its cleavage, but depends on its  
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Genotype of mice Phenotype References 
Caspase-8
-/-
 Embryonic lethal, die between E10.5 and 
E11.5; 
Varfolomeev et al., 1998 
Rip1
-/-
 Not embryonic lethal, but die quickly in 1-3 
days after birth; 
Kelliher et al., 1998 
Rip3
-/-
 Healthy and viable as wild type mice; Newton et al., 2004 
Fadd
-/-
 Embryonic lethal during mid-gestation stages Yeh et al., 1998 
cFLIP-/- Embryonic lethal during mid-gestation stages Yeh et al., 2000 
Caspase-8
-/-
Rip3
-/-
 Rescued from embryonic lethality, viable 
and mature into fertile adults but develop 
lymphadenopathy when getting old; 
Oberst et al., 2011; 
Kaiser et al., 2011; 
 
Fadd
-/-
Rip1
-/-
 Rescued from embryonic lethality, but die 
quickly after birth; 
Zhang et al., 2011 
Fadd
-/-
Rip3
-/-
 Rescued from embryonic lethality, viable 
and mature into fertile adults but develop 
lymphadenopathy when getting old; 
Dillon et al., 2012 
Caspase-8
-/-
Rip1
-/-
 Rescued from embryonic lethality, but die 
quickly after birth; 
Dillon et al., 2014 
Rip1
-/-
Rip3
-/-
Casp8
-/-
 Rescued from embryonic lethality, viable 
and mature into fertile adults but develop 
lymphadenopathy when getting old; 
Dillon et al., 2014; 
Rickard et al., 2014; 
Kaiser et al., 2014; 
Rip1
-/-
Rip3
-/-
Fadd
-/-
 Rescued from embryonic lethality, viable 
and mature into fertile adults but develop 
lymphadenopathy when getting old; 
Dillon et al., 2014 
Rip3
D161N/D161N Embryonic lethal, die around E11.5; Newton et al., 2014 
Casp8
-/-
 
Rip3
D161N/D161N
 
Rescued from embryonic lethality, viable 
and mature into fertile adults but develop 
lymphadenopathy when getting old; 
Newton et al., 2014 
Rip1
D138N/D138N
 Healthy, normal as wild type mice; Newton et al., 2014 
Rip1
K45A
 Healthy, normal as wild type mice; Berger et al., 2014; 
Kaiser et al., 2014; 
Mlkl
-/-
 Healthy and viable as wild type mice; Murphy et al., 2013; 
Wu et al., 2013; 
 
Table 1.1 The phenotypes of genetically modified mice. 
 
  
22 
 
catalytic activity (Oberst et al., 2011). Oberst et al. also propose that the ability of caspase-8 to 
inhibit RIP3-mediated necrosis requires the expression of FLIP, and caspase-8-FLIP heterodimers 
are enzymatically active to inhibit necrosis, which does not require the cleavage of caspase-8 
between its large and small subunits. This is consistent with the similar embryonic lethality 
phenotype of FADD deficient, or FLIP deficient mice to caspase-8 deficient mice (Yeh, 1998; 
Yeh et al., 2000). These studies suggest that the main non-apoptotic role of caspase-8 is to 
suppress RIP3-mediated necrosis, potentially through cooperation with FLIP and FADD. This 
conclusion is partially supported by another work by Zhang et al. (2011). Similar as the 
embryonic lethality of Casp8-/- mice, Fadd-/- mice die during mid-gestation stages with extensive 
necrotic cell death and elevated expression of RIP1 in embryos (Yeh et al., 1998), whereas RIP1 
deficiency restores normal embryonic development of Fadd-/- mice. Although Fadd-/- Rip1-/- 
double-knockout mice acquire normal embryogenesis, most of them die within 4 days after birth, 
consistent with Rip1-/- mice which die 1-3 days after birth (Kelliher et al., 1998). The phenotypes 
of these genetically deficient mice suggests that FADD can keep RIP1-mediated necrosis in 
check, probably through acting in concert with caspase-8 to cleave and inactivate RIP1 (Zhang et 
al., 2011).  
 
The investigations mentioned above suggest that caspase-8 has two different roles in cell death, 
as inducers of apoptosis and inhibitors of RIP3-mediated necrosis. For RIP1, it can either prompt 
caspase-8-mediated apoptosis, or coordinate with RIP3 to induce necrosis, depending on its 
modification and the intracellular circumstance. So far, it looks like that RIP3 only has one role in 
this game, to induce necrosis. However, the results of a very recent study challenge this 
conclusion. In contrast to the viability and normality of Rip3-/- mice, engineered mice expressing 
catalytically inactive RIP3 D161N (Ripk3D161N/D161N) die around embryonic day 11.5 (E11.5) with 
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abnormal yolk sac vasculature (Newton et al., 2014). When the kinase activity of RIP3 is 
inhibited by mutating Asp161 of the catalytically important DFG motif to Asn, apoptosis is 
significantly increased in the Ripk3D161N/D161N yolk sac vasculature. In addition, the double mutant 
Casp8
-/-
 Ripk3
D161N/D161N mice, generated by breeding the Ripk3D161N allele onto a caspase-8-null 
background, are viable and show similar lymphadenopathy with Casp8-/-Rip3-/- DKO mice, 
suggesting that RIP3 D161N mutation induce embryonic lethality through prompting caspase-8-
dependent apoptosis during embryogenesis (Newton et al., 2014). RIP1 deficiency rescued 
embryonic lethality caused by RIP3 D161N, but the Rip1-/- Ripk3D161N/D161N mice die soon after 
birth, similar to Rip1-/- mice, suggesting that although RIP1 deficiency can suppress the apoptosis 
which leads to embryonic lethality, the other defects caused by RIP1 loss still incite the postnatal 
lethality and do not require RIP3 kinase activity-dependent necrosis. Newton et al. also 
constructed the Ripk3D161N/D161N embryos lacking MLKL, TRIF, DAI, CYLD, TNFR1 or FLIP, 
and none of them survive beyond E11.5, demonstrating that these proteins are dispensable for 
RIP3 D161N-induced apoptosis. Last, the Rip1 kinase dead knock-in mice, with Asp138 of the 
HKD motif necessary for RIP1’s kinase activity mutated to Asn (Ripk1D138N/D138N mice), are 
viable. This is in contrast to the postnatal death of Rip1-/- mice, suggesting that RIP1 kinase 
activity is critical for necrosis, but not required for caspase-8-mediated apoptosis. Using the 
primary cells from Ripk1D138N/D138N mice, it is further confirmed that RIP1 kinase activity is 
dispensable for NF-κB and MAPK activation (Newton et al., 2014).  
 
To further investigate the mechanisms of postnatal lethality of Rip1-/- mice, three very recent 
studies have constructed Rip1-/-Rip3-/-Casp8-/- or Rip1-/-Rip3-/-Fadd-/- mice, which behave normally 
after birth in contrast to Rip1-/- mice, suggesting the postnatal lethality of Rip1-/- mice is induced 
by the synergy of caspase-8 and RIP3 (Dillon et al., 2014; Kaiser et al., 2014; Rickard et al., 
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2014). Collectively, as summarized in Table 1.1, the phenotypes of various genetically modified 
mice dipict a picture that FADD-caspase-8-FLIP interacts with RIP1-RIP3-MLKL to regulate cell 
death during embryonic development and postnatal period.  
 
Cell death is closely interlinked with inflammation. During necrosis, cellular components are 
released and can trigger inflammation. Apoptosis is originally recognized as “silent” cell death, 
not inducing inflammation. But recent studies also suggest that there is inflammatory responses 
accompany the induction of apoptotic cell death (Hotchkiss and Nicholson, 2006; Verfaillie et al., 
2013). Moreover, caspase-8, RIP1 and RIP3 are found not only contributing to cell death, but also 
contributing to inflammation. As mentioned earlier in the inflammasome section, caspase-8 can 
induce the cleavage of pro-IL-1β into mature cytokines, possibly bypassing the canonical known 
NLR inflammasomes (Maelfait et al., 2008; Gringhuis et al., 2012). RIP3 is also found to have 
the potential capability to activate NLRP3 inflammasome and IL-1β release, although this 
capability is blocked by caspase-8 in normal situation. Only when caspase-8 is genetic deficient 
or chemically inhibited, RIP3-mediated inflammasome activation can be liberated (Kang et al., 
2013). Based on these studies, what we can conclude only is that the interplay between RIP1, 
Caspase-8 and RIP3 during apoptosis, necrosis and inflammation, is complicated and more efforts 
are needed to clarify these issues. 
 
Pyroptosis 
Pyroptosis is a recently defined pro-inflammatory form of cell death which is mediated by 
inflammasome-induced caspase-1 activation. Pyroptosis shares some morphology characteristics 
with both apoptosis and necrosis, with nuclear condensation and oligonucleosomal DNA 
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fragmentation as well as cytoplasm membrane rupture (Bergsbaken et al., 2009). Pyroptosis 
occurs in response to a number of bacterial infections, including Salmonella enterica serovar 
Typhimurium, Shigella flexneri,  Legionella pneumophila, Pseudomonas aeruginosa, Francisella 
tularensis and so on (Bergsbaken et al., 2009; Miao et al., 2011). Inflammasome-mediated 
caspase-1 activation also triggers maturation and release of pro-inflammatory cytokines IL-1β 
and IL-18, however, studies indicate that pyroptosis is independent of IL-1β and IL-18.  
Pyroptosis could be either beneficial or detrimental for the host defense against infection, just 
depending on whether there is mechanism (like neutrophil phagocytosis) to resolve the bacteria 
released during cell death and tissue inflammation induced by pyroptosis. Without caspase-1 or 
neutrophil-mediated phagocytosis, the lysis of macrophages and the release of intracellular 
Salmonella during the occurrence of pyroptosis will be detrimental for the host (Broz et al., 2012; 
Miao et al., 2010). 
 
Although pyroptosis is defined as the cell death induced by caspase-1, recent studies found that 
non-canonical caspase-11 activation also contributes to caspase-1-independent cell death in 
response to E. coli, C. rodentium, V. cholerae and S. Typhimurium (Broz et al., 2012; Kayagaki 
et al., 2011).  Since the previously used caspase-1 knockout mice also lack a functional allele of 
Caspase-11, the caspase-1 knockout mice actually turn out to be functional Casp1 Casp11 double 
knockouts (Kayagaki et al., 2011). Thus, it is worth investigating the individual roles of caspase-1 
and caspase-11 in the cell death using real single knockout animals. The study by Broz et al. 
suggested that wild-type Salmonella induces cell death through two separate pathways, canonical 
pyroptosis (flagellin recognition by NLRC4 which activates caspase-1) and non-canonical 
pathway which requires caspase-11 (Broz et al., 2012). The cell death mediated by caspase-11 
shows similar characteristics as pyroptosis. Regarding the mechanism underlying caspase-11 
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activation, both Broz et al. and the simultaneous study by Rathinam et al. indicated that TRIF-
dependent interferon production is crucial for caspase-11 activation (Rathinam et al., 2012). 
However, further investigations are needed to clarify the mechanism of caspase-11-induced cell 
death, and the individual roles of caspase-1 and caspase-11 in pyroptosis. 
 
Yersinia pestis 
Overview 
Yersinia pestis, a Gram-negative bacteria, belongs to the genus Yersinia, which contains three 
species known to be pathogenic to humans: Yersinia enterocolitica, Yersinia pseudotuberculosis 
and Yersinia pestis. Y. enterocolitica and Y. pseudotuberculosis cause food-borne and waterborne 
enteric diseases. Yersinia pestis is the causative agent of plague, which has caused three major 
pandemics in history, including the infamous Black Death in medieval Europe. The three 
pandemics have caused the deaths of an estimated 200 million people and had huge impact on 
western society and human civilization (Perry and Fetherston, 1997). Nowadays, although 
infection with Yersinia pestis can often be treated by timely use of antibiotics and plague 
outbreaks are rare worldwide, this bacterium is still a concern for bioterrorism and recognized as 
a category A select agent (Butler, 2009).  
 
 Y. pestis can be spread via flea bites, which result in classical bubonic plague with the 
characteristic swollen lymph nodes, or buboes. Septicemic plague occurs when the bacteria enters 
the blood stream and spreads systemically. Once the infection has become systemic, the 
bacterium can colonize the lung and can aerosolize when the patient coughs. Hence it can be 
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spread person-to-person through aerosol droplets, which leads to occurrence of pneumonic plague. 
The bubonic and septicemic plague are fatal in 30-70% of cases within 5-10 days if not treated 
with antibiotics, while pneumonic plague has a much shorter incubation period of only 1-3 days 
and causes a 100% fatality without treatment (Perry and Fetherston, 1997).    
 
Y. pestis is a bacterium with high virulence, leading to such serious diseases in a relatively short 
time. This is achieved by establishing infection and replicating quickly in host tissues, which 
requires that Y. pestis is capable of evading the host innate immune surveillance at the beginning 
of infection. In order to shut down host’s innate immune responses, Y. pestis is evolved to possess 
several mechanisms as its crucial virulence factors, including type III secretion system (T3SS), 
out membrane protease Pla with plasminogen activator activity, non-stimulatory LPS synthesis at 
mammalian temperature 37°C, F1 capsular antigen (Caf1) expressed at higher-temperature (37°C) 
environment and multiple iron acquisition systems (Cornelis, 2002; Sodeinde et al., 1992).  These 
mechanisms enable Y. pestis to invade the host innate immune system very efficiently, and thus 
make Y. pestis a good model infectious agent to study the relationship between host innate system 
and bacterial infection. 
 
Non-stimulatory LPS synthesis at 37°C 
Many Gram-negative bacteria produce a hexa-acylated lipid A and LPS, as one of their important 
PAMPs, to trigger strong innate immune responses through TLR4-MD2 signaling (Munford, 
2008; Rebeil et al., 2004). However, Y. pestis synthesizes different lipid A and LPS with varied 
structures at different growth conditions. At 26°C (flea temperature), the lipid A portion of LPS is 
mainly hexa-acylated, similarly to the LPS of many other Gram-negative bacteria. When 
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temperature is shifted to 37°C (mammalian host temperature), the lipid A produced by Y. pestis 
also changes to be tetra-acylated (Kawahara et al., 2002; Knirel et al., 2005; Rebeil et al., 2004). 
Tetra-acylated lipid A/LPS is antagonistic to human TLR4/MD2 and can poorly activate TLR4-
mediated immune pathways, and it is also a weak agonist towards mouse cells (Kawahara et al., 
2002; Knirel et al., 2005; Montminy et al., 2006). This lipid A variance phenotype is due to the 
absence of LpxL, a late-acyl transferase that is responsible for adding a secondary acyl chain on 
to the tetra-acylated lipid A precursor molecule in Y. pestis. At lower temperatures, Y. pestis 
expresses a late acyltransferases LpxP, which is a cold-shock-induced enzyme and supposedly 
not active at high temperature 37°C. LpxP cooperates with LpxM, another late acyltransferase, to 
produce the hexa-acylated lipid A/LPS at 26°C (Rebeil et al., 2006). Through expressing E. coli 
or Y. pseudotuberculosis LpxL in Y. pestis, these modified Y. pestis (Y. pestis-EcLpxL or Y. 
pestis-YtbLpxL) strains can produce hexa-acylated lipid A/LPS at 37°C and thus can activate 
TLR4/MD2 pathway to boost a strong innate immune response (Montminy et al., 2006; Vladimer 
et al., 2012). In vitro, Y. pestis-EcLpxL or Y. pestis-YtbLpxL activate macrophages to produce 
higher pro-inflammatory cytokines, IL-6 and TNFα than wild type Y. pestis. Further in vivo 
investigations by our group have confirmed that the expression of LpxL in Y. pestis significantly 
reduces the virulence in wild-type mice, but not in TLR4 KO mice, suggesting that synthesis of 
non-stimulatory LPS at 37°C is a virulence strategy utilized by Y. pestis to evade the host innate 
immune responses (Montminy et al., 2006; Vladimer et al., 2012).   
 
Type three secretion system (T3SS) and YopJ 
Type three secretion system (T3SS), which is encoded by the virulence plasmid pCD1 and 
required for virulence of all three pathogenic Yersinia species, is a needle-like machinery to inject 
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several effector proteins into cytoplasm of host cells. These effector proteins are Yops (Yersinia 
outer proteins) and LcrV. There are seven Yop effector proteins, YopE, YopH, YopT, YopM, 
YpkA (YopO), YopK and YopJ. The expression and activation of T3SS and Yops are 
temperature regulated. Upon shift of temperature from 26°C (flea temperature) to 37°C, the 
expression of Yersinia T3SS is upregulated (Cornelis, 2002; Viboud and Bliska, 2005). When the 
bacteria come into contact with the host cells, the T3SS is further activated and the expressed 
Yop effectors are secreted and delivered into the cytoplasm of host cells (Pettersson et al., 1996).  
These Yop effectors can modulate host cells signaling pathways and thus interfere with the 
immune responses of these targeted host cells, attenuating both innate and adaptive immune 
responses. YopB and YopD are two structure Yops to form the T3SS needle with LcrV. YopE, 
YopH, YopT and YpkA inhibit dynamics of the actin cytoskeleton and therefore interfere with 
the phagocytosis of macrophages and neutrophils (Perry and Fetherston, 1997; Viboud and Bliska, 
2005). YopE is a GTPase-activating protein and it can inactivate the Rho family of small 
GTPases. YopH is a protein tyrosine phosphatase. YopT is a cysteine protease to cleave the Rho 
GTPases and detach the Rho GTPases from the membrane and prevent membrane anchoring 
YpkA is an autophosphorylating serine/threonine kinase and can interact with members of the 
Rho family GTPases. Since Rho family GTPases are critically involved in actin cytoskeleton 
function, these four Yops target these GTPases to interfere with cytoskeleton and limit the 
internalization and phagocytosis of Yersinia by macrophages (Trosky et al., 2008; Viboud and 
Bliska, 2005).  
 
YopJ (YopP in Y. enterocolitica) is an interesting effector protein with multiple different effects. 
It was first found to inhibit NF-κB and MAPK pathways and thereby repress the production of 
pro-inflammatory cytokines, including IL-6 and TNFα (Palmer et al., 1998; Schesser et al., 1998). 
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Meantime, two groups reported that YopJ can also induce robust apoptotic cell death in 
macrophages (Mills et al., 1997; Monack et al., 1997). YopJ has a catalytic domain which is 
similar to cysteine proteases. Alignment of the amino acid sequences revealed a conserved 
catalytic triad His109-Glu128-Cys172 for cysteine protease in YopJ (Orth et al., 2000). Mutation 
of the catalytic triad of YopJ abolishes its ability to inhibit NF-κB and MAPK pathways as well 
as prompt apoptosis (Orth et al., 2000). The molecular mechanism by which YopJ inhibits NF-κB 
and MAPK pathways has gained intensive investigation. It was first proposed that YopJ functions 
as a de-SUMOylating protease, but the targets were not identified (Orth et al., 2000). Later 
studies suggested YopJ acts as a de-ubiquitinase to cleave polyubiquitin chains from TRAF6, 
which is an essential NF-κB pathway protein (Sweet et al., 2007; Zhou et al., 2005). Until 2006, 
two groups showed solid biochemical evidence which indicated that YopJ is a serine/threonine 
acetyltransferase. Using a cell-free signaling system and mass spectrometry (MS/MS) approach, 
Mukherjee et al. indicated that YopJ can acetylate the critical serine (ser207) and threonine 
(thr211) residues in the activation loop of MAPKK6 and thereby inhibit MAPKK6’s 
phosphorylation and activation (Mukherjee et al., 2006). Mittal et al. expressed YopJ or YopJ 
C172A mutant in Hela cells and discovered that YopJ can acetylate the serine and threonine 
residues of MEK2, IKKα and IKKβ to inhibit their phosphorylation and activation (Mittal et al., 
2006). A subsequent study by Paquette et al. reported that YopJ inhibits Drosophila’s innate 
immune NF-κB pathway (IMD) but not the Toll pathway. YopJ mediates the serine/threonine 
acetylation and inhibition of TAK1 in both Drosophila and mammalian cells, suggesting that 
TAK1 is another direct target acetylated and inhibited by YopJ (Meinzer et al., 2012; Paquette et 
al., 2012). TAK1 lies upstream of IKKα/β, MKK6 and MKK4 in NF-κB and MAPK pathways 
and this suggests that the acetyltransferase activity of YopJ is not limited to MAP2 and IKKα/β 
kinases, and YopJ may have more other targets in host cells.  
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These above studies elegantly explain how YopJ targets and inhibits NF-κB and MAPK signaling 
pathways. For the underlying mechanism of YopJ-induced apoptosis, it was believed that the NF-
κB and MAPK pathways inhibitory activity of YopJ suppresses the transcription and expression 
of pro-survival genes and anti-apoptotic genes, leading to the apoptotic death in macrophages. 
However, through expressing two inhibitors of the NF-κB pathway, IκBα superreprssor or A20 in 
macrophages, Zhang et al. indicated that inhibition of the NF-κB pathway is not sufficient for 
rapid Yersinia-induced apoptosis. Even when macrophages expressing A20 were pretreated with 
combined three MAPK pathways’ inhibitors, the apoptosis level induced by YopJC172A mutant 
is still lower than wild type Yersinia, suggesting that there is other mechanism targeted by YopJ 
to trigger apoptotic cell death (Zhang et al., 2005). During Yersinia infection, TLR4 plays an 
important role in mediating NF-κB and MAPK pathways activation by LPS. When NF-κB 
pathway or protein synthesis is inhibited, TLR4 activation will prompt cell death (Ruckdeschel et 
al., 1998, 2001). Since Yersinia produces both LPS and NF-κB inhibitor, YopJ, it is proposed that 
YopJ potentiates the apoptotic signaling of LPS mediated by TLR4 through inhibiting NF-κB 
pathway (Ruckdeschel et al., 2001). Results from both the Ruckdeschel and Bliska groups 
indicated that although macrophages deficient in TLR4 function are more resistant to Yersinia-
induced cell death, there are still around 50% of apoptosis remaining in TLR4 deficient cells, 
suggesting that TLR4 contributes to YopJ-mediated apoptosis but is not absolutely required 
(Haase et al., 2003; Zhang and Bliska, 2003). Interestingly, regarding the two adaptors 
downstream of TLR, TRIF deficient cells show similar partial protection from Yersinia-induced 
cell death as TLR4 deficient cells. In contrast, MyD88 knockout macrophages are not protected at 
all and with similar cell death rate as wild type cells (Ruckdeschel et al., 2004).  Moreover, in 
dendritic cells, YopP of Y. enterocolitica induces caspase cleavage but also triggers a caspase-
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independent necrosis-like cell death (Gröbner et al., 2006). The same group subsequently 
demonstrated that Y. enterocolitica infection induces the formation of a FADD/caspase-8/RIP1 
DISC complex and caspase-8, caspase-3 activation in dendritic cells (Gröbner et al., 2007). As we 
mentioned in last section of cell death pathways, TRIF is able to interact with RIP1 via their 
RHIM domains, leading to programmed necrosis through RIP1 and RIP3. These studies suggest 
that Yersinia YopJ/YopP-mediated cell death might involve TLR4, TRIF, RIP1 and caspase-8, 
but how these molecules contribute to the process still remain elusive. 
 
Beyond the activity to inhibit NF-κB and MAPK pathways and induce apoptosis, YopJ has been 
found to induce inflammasome activation, leading to caspase-1 cleavage, IL-1β and IL-18’s 
maturation and release (Lilo et al., 2008; Vladimer et al., 2012), although several mechanisms 
may be involved and are still under investigation. Zheng et al. suggested that YopJ does not 
directly activate the NLRs, but its inhibitory activity on the NF-κB pathway leads to NLRP3 
inflammasome activation (Zheng et al., 2011). Our group also observed that both NLRP12 and 
NLRP3 are inflammasome components which are required for optimal Y. pestis-induced caspase-
1 activation and IL-1β, IL-18 secretion. The production of IL-1β and IL-18 are markedly reduced, 
but not completely abrogated, in NLRP12 KO and NLRP3 KO compared to wild type BMDMs, 
suggesting there is redundancy or cooperation between NLRs to mediate inflammasome 
activation by Y. pestis. Moreover, NLRP12 KO, NLRP3 KO, IL-1β KO, IL-1R1 KO and IL-18 
KO mice are more susceptible to Y. pestis-ytbLpxL infection, suggesting the inflammasome 
pathways contribute to innate response thus protective effect against Yersinia infection (Vladimer 
et al., 2012). In addition, as other pore-forming toxins or specialized secretion systems of 
bacterial pathogens, T3SS machinery itself can also induce both NLRP3 and NLRC4 
inflammsomes’ activation (Brodsky et al., 2010). Therefore, there are at least two independent 
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mechanisms utilized by Yersinia to induce inflammasome activation and caspase-1 cleavage. 
However, under normal conditions, another Yersinia T3SS secreted effector protein, YopK, can 
interact with the T3SS translocon, regulate effector proteins translocation and prevent the 
detection of the T3SS by host cell, and thus block the T3SS-mediated inflammasome activation. 
Hence, the inflammasome-mediated caspase-1 activation is mainly due to YopJ in wild type 
Yersinia infection. When YopK is deficient, the T3SS-induced inflammasome assembly will 
stand out to induce rapid caspase-1 cleavage and IL-1β, IL-18 secretion (Brodsky et al., 2010). 
This also explains why caspase-1 activation is inhibited when infected with Yersinia ΔYopJ 
mutant which has an intact functional bacterial T3SS. A more recent study indicated that YopM, 
another Yop effector of T3SS, can directly bind to caspase-1 to arrest inflammasome assembly 
and activation, although this was only implicated with Y. pseudotuberculosis and the role of 
YopM in Y. pestis is unknown (LaRock and Cookson, 2012). For Yersinia-induced NLR 
inflammasomes activation, including NLRP3, NLRC4 and NLRP12, it seems like that different 
Yop effectors, YopJ, YopK, YopM as well as T3SS translocon itself are involved, but more 
studies are need to elucidate the tangled relationship between these molecules and their respective 
roles.  
 
It is impressive that this single effector protein, YopJ, exerts so many distinct effects in vitro, 
inhibiting NF-κB and MAPK signaling pathways, inducing rapid apoptosis of macrophages and 
dendritic cells, as well as activating inflammasomes and caspase-1 cleavage, resulting in IL-1β 
and IL-18 maturation and secretion. During these effects, NF-κB inhibition by YopJ will repress 
the “signal 1” of mature IL-1β secretion, dampening the transcription and expression of pro-IL-1β. 
But at the same time, YopJ can prompt “signal 2”, and trigger the caspase-1 cleavage to process 
pro-IL-1β into mature cytokines. Therefore, for mature IL-1β production, YopJ itself shows 
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contradictory and opposing effects. With such impressive effects in vitro, it is interesting to 
investigate the role of YopJ in Yersinia virulence through in vivo infections.  Results indicate that 
the role of YopJ/YopP in virulence varies in different Yersinia species and in different inoculation 
models. In Y. pseudotuberculosis-induced gastrointestinal disease via the oral infection route, 
YopJ has been shown to induce apoptosis in infected mesenteric lymph nodes or spleens and this 
correlates with increased bacterial replication in the tissues. Moreover, the oral LD50 for a yopJ 
mutant Y. pseudotuberculosis increases 64-fold compared with wild type bacteria in BALB/c 
mice, and the yopJ mutant strain is dampened for systemic spread from the Peyer’s patches to 
other lymphoid tissues (Monack et al., 1998). Through a sublethal intragastric mouse infection 
model by Y. pseudotuberculosis, YopJ is demonstrated to promote sustained systemic 
colonization in C57BL/6 mice, which is associated with the cytotoxicity of YopJ.  Moreover, 
wild type Y. pseudotuberculosis induces higher levels of IL-18 and IFN-γ cytokines than the yopJ 
mutant strain in mouse serum, and this correlates with the YopJ-mediated inflammasome-
caspase-1 activation and IL-1β, IL-18 maturation effect in vitro (Zhang and Bliska, 2010).  
However, in this infection model, the survival curves for mice infected with three different doses 
of yopJ mutant strain are not significantly different from those mice infected with the wild type Y. 
pseudotuberculosis, suggesting that YopJ is not a critical virulence factor of Y. 
pseudotuberculosis serogroup O:1 strain 32777 (previously known as IP2777) using this specific 
infection procedure (Zhang and Bliska, 2010). Subsequently, Meinzer et al. (2012) demonstrated 
that Y. pseudotuberculosis YopJ contributes to intestinal barrier dysfunction and intestinal 
permeability, thus promotes the bacterial dissemination from the gut to mesenteric lymph nodes 
and spleen. YopJ-induced intestinal barrier dysfunction is suggested to associate with YopJ’s 
inhibitory act on Nod2/RICK/TAK1 pathway, resulting in caspase-1 activation and IL-1β 
secretion in Peyer’s patches. For mouse infection induced by orogastric inoculation, YopJ 
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deficiency delays the mortality of infected mice significantly, although it does not greatly alter 
the power of Y. pseudotuberculosis to kill mice (Meinzer et al., 2012).  At the same time, another 
group published similar results that Y. pseudotuberculosis triggers Peyer’s patches barrier 
dysfunction through inducing caspase-1 activation and IL-1β production (Jung et al., 2012). 
These studies consistently indicate that YopJ of Y. pseudotuberculosis has only a limited impact 
on global bacterial virulence, by prompting bacterial dissemination via dysfunctional intestinal 
barrier and this correlates with YopJ-induced apoptotic cell death, caspase-1 activation and IL-1β 
secretion. 
 
However, for the role of YopJ in Y. pestis virulence, the case seems to be different. In septicemic 
plague model through intravenous infection with an attenuated Y. pestis strain, yopJ mutant only 
increases the LD50 by 1.2- to 1.5-fold compared with wild type bacteria (Straley and Bowmer, 
1986; Straley and Cibull, 1989). In a rat model of bubonic plague through intradermal (ID) 
inoculation with the fully virulent Y. pestis 195/P strain, ΔyopJ mutant is fully virulent as wild 
type strain, with similar survival rate, clinical signs, systemic spread and colonization (Lemaître 
et al., 2006). Additionally, in this infection model, YopJ contributes to more apoptotic cells in the 
bubo lymph node and suppression of TNFα production in serum, that are consistent with YopJ’s 
in vitro effect. However, neither the decreased apoptosis in the bubo nor the increased serum 
TNFα level by the ΔyopJ mutant was sufficient to significantly affect Y. pestis virulence 
(Lemaître et al., 2006).  
 
In summary, through oral infection, YopJ/P of Y. pseudotuberculosis and Y. enterocolitica 
contributes to systemic spread of bacteria and barrier dysfunction. But for bubonic plague 
induced by s.c. infection, YopJ is dispensable and there is no significant phenotype when 
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infecting with Y. pestis ΔYopJ. Hence, the in vivo virulence role of YopJ might depend on 
different infection routes and models. The molecular mechanism of YopJ-induced apoptosis and 
inflammasome activation, and the in vivo role of YopJ in different infection models and the 
underlying mechanism between bacteria-host interaction need further investigation.   
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Caspase-8 and RIP kinases regulate bacteria-induced innate 
immune responses and cell death 
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Abstract 
A number of pathogens cause host cell death upon infection, and Yersinia pestis, infamous for its 
role in large pandemics such as the “Black Death” in medieval Europe, induces considerable 
cytotoxicity. The rapid killing of macrophages induced by Y. pestis, dependent upon type III 
secretion system effector YopJ, is minimally affected by the absence of caspase-1, caspase-11, 
Fas ligand or TNFα. Caspase-8 is known to mediate apoptotic cell death in response to infection 
with several viruses and to regulate programmed necrosis (necroptosis), but its role in bacterially-
induced cell death is poorly understood. Here we provide genetic evidence for a Receptor-
Interacting protein (RIP) kinase-caspase-8-dependent macrophage apoptotic death pathway 
following infection with Y. pestis, influenced by TLR4-TRIF. Interestingly, macrophages lacking 
either RIP1, or caspase-8 and RIP3, also had reduced infection-induced production of IL-1β, IL-
18, TNFα and IL-6; impaired activation of the transcription factor NF-κB; and greatly 
compromised caspase-1 processing. Cleavage of the pro-form of caspase-1 is associated with 
triggering inflammasome activity which leads to the maturation of IL-1β and IL-18, cytokines 
important to host responses against Y. pestis and many other infectious agents. Our results 
identify a RIP1–caspase-8/RIP3-dependent caspase-1 activation pathway following Y. pestis 
challenge. Mice defective in caspase-8 and RIP3 were also highly susceptible to infection and 
displayed reduced pro-inflammatory cytokines and myeloid cell death. We propose that caspase-8 
and the RIP kinases are key regulators of macrophage cell death, NF-κB and inflammasome 
activation, and host resistance after Y. pestis infection.  
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Introduction 
Yersinia pestis, the causative agent of plague, is well known to cause significant cell death upon   
infection through its type three secretion system (T3SS) effector YopJ (Lilo et al., 2008; 
Lukaszewski et al., 2005; Philip and Brodsky, 2012). Like the activation of inflammatory 
pathways to produce cytokines, triggering cell death pathways is a common response of the 
mammalian immune system to infection. Death of immune cells can eliminate the replication 
niche of pathogens found within those cells, thus inhibiting the proliferation of the pathogens and 
exposing them to bactericidal mechanisms (Miao et al., 2010). Conversely, elimination of key 
immune cells can diminish the ability of those cells to respond to infection. Multiple host and 
microbial factors control cell death pathways (Lamkanfi and Dixit, 2010). Apoptosis, receptor 
interacting protein-1 (RIP1) and RIP3-dependent necroptosis, and caspase-1/caspase-11-
dependent pyroptosis constitute three major modes of regulated cell death during infection 
(Lamkanfi and Dixit, 2010; Vanlangenakker et al., 2012). Apoptosis is the best characterized 
programmed cell death and depends on the caspase family.  Various stimuli induce the activation 
of initiator caspases, including caspase-8, caspase-9 and caspase-10, which subsequently activate 
the effector caspases, such as caspase-3 and caspase-7.  
 
Several viruses appear to induce caspase-8 dependent apoptosis (Mocarski et al., 2012). Caspase-
8 has also been suggested to have additional non-apoptotic functions, such as inhibiting 
necroptosis (Kaiser et al., 2011; Mocarski et al., 2012; Oberst et al., 2011) and modulation of NF-
κB activation in T and B cells (Su et al., 2005). Signaling to the transcription factor NF-κB 
controls the transcription of cytokines such as IL-6, TNF, pro-IL-1β and pro-IL-18, and 
stimulates cell survival. Y. pestis can induce cell death in macrophages and dendritic cells via the 
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T3SS effector YopJ (YopP in Y. enterocolitica), although it is unclear whether this is entirely by 
apoptosis (Gröbner et al., 2007; Zheng et al., 2012). All human-pathogenic Yersiniae (Y. pestis, Y. 
pseudotuberculosis and Y. enterocolitica) harbor cytotoxic properties towards host cells, and 
YopJ production is associated with cell death both in vivo and in vitro (Brodsky and Medzhitov, 
2008; Brodsky et al., 2010; Monack et al., 1998; Zhang and Bliska, 2010). YopJ-mediated 
inhibition of NF-κB by acetylation of IKKβ, MAP kinase kinases, and TAK1 may modulate 
macrophage death via effects on inflammatory and pro-survival signals  (Greten et al., 2007; 
Meinzer et al., 2012; Mittal et al., 2006; Mukherjee et al., 2006; Paquette et al., 2012; Philip and 
Brodsky, 2012). Inflammasome activation, culminating in the activation and processing of 
caspase-1, leads to the production of IL-18 and IL-1β, key inflammatory cytokines and anti-
bacterial defenses, but can also be associated with caspase-1 dependent pyroptotic cell death 
(Vladimer et al., 2013). YopJ also participates in inflammasome activation (Brodsky et al., 2010; 
Zheng et al., 2011) leading to a host immune response. Thus, this single bacterial effector may 
induce both protective and harmful effects for the host. In the present study, we investigated the 
mechanisms for Y. pestis-induced cell death, NF-κB activation and inflammasome activation. 
 
Materials and Methods 
Mice 
Mice were maintained in specific-pathogen-free conditions at UMass Medical School and all 
experiments involving animals were approved by the Institutional Animal Care and Use 
Committee of the UMass Medical School. RIP3-/- caspase-8-/- double-deficient mice (Rip3-/-
xCasp8-/-) (DKO) (Kaiser et al., 2011) mice were generated by W. Kaiser and E. Mocarski and 
were bred 6-10 generations into C57Bl/6. Rip3 (RIP3-/-) mice were generated by V. Dixit 
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(Genentech) (Newton et al., 2004). Caspase-8fl/fl LysM cre+/+ (CKO) mice on a C57Bl/6 
background were generated at the University of Washington with a Caspase-8fl/+ allele provided 
by S. Hedrick (Beisner et al., 2005). C57Bl/6 mice were bred in-house or from the Jackson 
Laboratory.   
 
Mice lacking IFNαβR1 (Ifnar1-/-) were from J. Sprent (The Scripps Research Institute). FasL-/- 
(Fasl-/-) and TNF-α-/- (Tnf-/- on a LCMV CTL P14 background, with corresponding WT controls) 
mice were from A. Marshak-Rothstein, R. Welsh and The Jackson Laboratories. Mice lacking 
caspase-1 (Casp1-/- ; also containing a caspase-11 mutation), NLRP3 (Nlrp3-/-), NLRP3/NLRC4 
(Nlrp3-/-xIpaf-/-), NLRP12 (Nlrp12-/-), TLR4 (Tlr4-/-), TRIF (Ticam1-/-), or MyD88 (Myd88-/-) 
were from S. Akira, M. Starnback or Milennium Inc. as previously reported (Montminy et al., 
2006; Vladimer et al., 2012).  
 
Bone marrow transplantation (BMT) was performed on lethally (900 rads) irradiated C57Bl/6 
mice that were reconstituted with 4x106 cells from the indicated genotypes of mice. Mice were 
used for infections 6-10 weeks post transplantation, or when 6-12 weeks old (age/sex matched, 
similar numbers of each sex were used). Mice were infected subcutaneously (s.c) in the nape of 
the neck or intravenously (i.v.) with 500 CFU of KIM1001-pEcLpxL as reported (Montminy et 
al., 2006) and monitored for survival twice a day for up to 30 days; or sacrificed at ~42 hours 
post-infection for cytokine, CFU, tissue histology and cell death analysis. Sample collection was 
performed as previously described (Vladimer et al., 2012). Spleens from mice infected s.c. with 
300 CFU of KIM1001 were harvested 68 hrs post infection. Cytokine amounts from the spleen 
were normalized by spleen weight to account for any increases in tissue size during active 
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infection, since RIP3-/-caspase-8-/- mice show signs of markedly enlarged spleens by 6-8 weeks of 
age due to an increase in T cell numbers (Kaiser et al., 2011).  
 
Reagents  
Necrostatin-1 (Nec-1) was purchased from Enzo Life Sciences. Nigericin was from Sigma-
Aldrich. z-VAD-fmk was from Promega. Antibodies were purchased from the following vendors: 
RIP1 and β-actin (BD Pharmingen); Caspase-8 and cIAP1 (Enzo); Caspase-3, IκBα, pIκBα, 
pIKKα/β, IKKα and p65 (Cell Signaling); Caspase-1 (eBioscience); IL-1β (R&D Systsems), 
RIP3 (ProSci), ASC (Santa Cruz), Histone H3 (Abcam). Pam3Cys was obtained from Invivogen.   
 
Bacterial Strains and Growth Conditions   
Y. pestis KIM5 (containing the complete T3SS) or KIM5ΔYopJ was grown in tryptose-beef 
extract (TB) broth with 2.5 mM CaCl2 overnight with shaking at 26°C. The next day, the bacteria 
was diluted 1:8 into fresh media, cultured for one hour at 26°C and shifted to 37°C for two hours, 
or grown continuously at 37°C when indicated. KIM5-EcLpxL was grown similarly, but the 
culture medium was supplemented with 100 µg/ml ampicillin.  Y. pseudotuberculosis IP2666 and 
Y.enterocolitica 8081 (Vladimer et al., 2012) were grown at 37°C  in TB overnight, diluted and 
further cultured for three hours at 37°C. S. enterica serovar typhimurium strain SL1344 was 
provided by M. O’Riordan, and grown at 37°C with shaking. Generation of Y. pseudotuberculosis 
IP2666∆YopJ: an in-frame deletion removing codons 4-287 was created via allelic exchange. 
PCR products made with primer sets  
A (ATAGAGCTCCACTACTGATTCAACTTGGACG)  
and B (TCCGATCATTTATTTATCCTTATTCA), 
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and C (TGAATAAGGATAAATAAATGATCGGATAATGTATTTTGGAAATCTTGCT) and D 
(GGGTCTAGACTGATGTCGTTTATTTCTGGGTAT), respectfully, were used to make a fused 
product by overlap PCR using primers A and D (Horton et al., 1989). Generation of Y. pestis 
KIM5 ∆CaF1 (F1): an in-frame deletion removing codons 11-164 was created via allelic 
exchange. PCR products made with primer sets  
A (ATCGATGAGCTCCGTCACAGTAAGAGCACAACTT),  
B (GCAGCAGCAGCAGCATGGCGATAACGGAACTGAT)  
and C (TGCTGCTGCTGCTGCGTAACCGTATCTAACCAATAA),  
D (ATCGATGGTACCCTTCCAGTATCAGTGGGTTC), respectfully, were used to make a 
fused product by overlap PCR using primers A and D (Horton et al., 1989). For both strains, the 
PCR product was cloned in the allelic exchange vector pRE107 (Edwards et al., 1998) in E. coli 
K12 strain B2155, transferred to parental strains by conjugation, and recombinants selected on 
TB medium containing 100 μg/ml ampicillin with no diaminopimelic acid. Following counter-
selection with 5% sucrose, deletion mutants were identified by PCR. KIM5ΔYopJ was as 
described (Vladimer et al., 2012). Fully virulent KIM1001, and the attenuated strains KIM5-
EcLpxL and KIM1001-EcLpxL, expressing pBR322 containing E. coli lpxl and constitutively 
generating a TLR4-stimulating hexa-acylated lipid A, were as described (Montminy et al., 2006).   
 
Cell stimulations  
Mouse bone marrow-derived macrophages (BMDM) were prepared by maturing bone marrow 
cells for 6-7 days in the presence of M-CSF-containing supernatant from L929 cells. Some cell 
stimulations were also conducted with peritoneal macrophages and immortalized BMDM, and 
similar results to stimulations done with BMDM were obtained. RIP1+/+ and RIP1-/- immortalized 
fetal liver macrophages were provided by M. Kelliher and K. Fitzgerald. Mouse peritoneal 
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macrophages were harvested from mice 4 days after injection of 3 ml thioglycollate (injected by 
i.p.).  Mouse macrophages were plated at a density of 5x104 cells per well in 96-well dishes and 
incubated overnight. Bacterial infections were performed at the MOIs indicated and gentamicin 
(40µg/mL) was added 1 hr post-infection. Supernatants were collected for cytokine analysis or 
LDH assays at the indicated time points. In some experiments, cells were pre-treated with 1 uM 
of the RIP1 inhibitor GSK’963 or its inactive enantiomer GSK’962 (P.A.H., J.B., P.J.G., 
manuscript in preparation), 3 uM of the RIP3 inhibitor GSK’872, 20 µM Nec-1 (Enzo Life 
Sciences), 20 µM IETD, YVAD or zVAD (Promega) 1 hour prior to infection. 10 µM Nigericin 
(Sigma-Aldrich), 10 ng/ml of hexa-acylated LPS from Y. pestis grown at 26°C or from E. coli, 
and 300 ng/ml Pam3CysSK4 (Pam3Cys, Invitrogen) were used as controls. Cytokine levels and 
caspase-1 cleavage were measured by ELISA and western blot following the manufacturer’s 
instructions or as previously reported (Vladimer et al., 2012). ELISA antibodies or kits were from 
R&D systems (mouse TNF, IL-6, IL-18 and IL-1β). Caspase-8 activity (Promega) was measured 
2 hrs post infection. 
 
Western blot analysis  
Protein from cell supernatants was precipitated by methanol-chloroform extraction.  Adherent 
cells were lysed with 1% NP-40 lysis buffer (10% glycerol, 1% NP-40, 20 mM Tris-HCl pH 7.4, 
137 mM NaCl, 2 mM EDTA, containing protease inhibitors: 1 mM sodium orthovanadate, 1 mM 
PMSF and cOmplete Protease Inhibitor Cocktail (Roche).  Immunoblot analysis was mainly as 
previously described (Vladimer et al., 2012) with antibodies to mouse caspase-8 (clone: 1G12, 
Enzo Life Sciences), caspase-3 (clone: 5A1E, Cell Signaling), mouse caspase-1 p20 (clone: 5B10, 
eBioscience), mouse IL-1β (catalog #: AF-401-NA, R&D Systems), RIP1 (clone: 38/RIP, BD 
Transduction Laboratories), IκBα (catalog #: 9242, Cell Signaling), phospho-IκBα (catalog #: 
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2859, Cell Signaling), β-actin (BD Pharmingen), RIP3 (catalog #: 2283, ProSci), p65 (Cell 
Signaling) or Histone 3 (Abcam). 
 
LDH assay 
Cell death was measured by detecting the lactate dehydrogenase (LDH) release using the 
CytoTox-96 nonradioactive cytotoxicity kit (Promega) according to the manufacturer’s 
instructions. Background LDH release was determined by assaying supernatants from uninfected 
cells, and total LDH was determined from uninfected cells which had been lysed by lysis buffer. 
The percentage of cell death was calculated as: (sample LDH - background LDH)/(total LDH - 
background LDH) x 100%. 
 
FACS analysis 
Single-cell suspensions of splenocytes from infected animals or mouse macrophages were treated 
with Fc block (clone 93, rat anti-CD16/CD32, eBiosciences) for 15 minutes on ice, then stained 
with the indicated antibodies: CD40-APC (clone:1C10, eBiosciences) and CD11b–PE 
(clone:M1/70, eBiosciences). Where applicable, dead cells were enumerated using the live/dead 
blue stain (Invitrogen) or propidium iodide (PI staining solution, BD) according to the 
manufacturer’s instructions. Cells from infected mice were fixed with 2% formaldehyde prior to 
analysis by flow cytometry. Data acquisition was performed with an LSRII instrument (BD) and 
BD FACSDivaTM software, and analysis was conducted with FlowJo. 
 
Caspase-8 activation assay 
To determine the status of caspase-8 enzymatic activity, 1x105 cells were plated into each well of 
a 96-well plate and stimulated with Y. pestis at an MOI40 for 2 hours. Caspase-8 activation in cell 
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lysates was detected using Caspase-Glo® 8 Assay (Promega) according to the manufacturer’s 
instructions.  
 
qPCR analysis of Il1b expression in primary mouse macrophages 
RNA from resting or stimulated (with Y. pestis or LPS) BMDM was purified with the RNeasy 
Mini Kit (Qiagen) and cDNA was generated with the iScript cDNA Synthesis Kit (BioRad). PCR 
was performed as reported (Vladimer et al., 2012) on transcribed cDNA with primers for 
detection of mouse Il1b  
(5’–GCCCATCCTCTGTGACTCAT–3’, 5’–AGGCCACAGGTATTTTGTCG-3’) using SYBR 
green (BioRad) according to the manufacturer’s instructions.  
 
Staining and microscopy 
Tissue samples for histology were fixed in 10% buffered formalin for a minimum of 72 hours 
with 3 changes of fixative. Hematoxylin and eosin (H&E) staining and microscopy were 
performed as previously described (Montminy et al., 2006; Vladimer et al., 2012). 
 
Electron microscopy 
Wild-type, RIP3-/-caspase-8-/-, or RIP3-/- immortalized mouse macrophages were infected with Y. 
pestis KIM5 for 2.5 hours and subjected to electron microscopy analysis by the UMass Medical 
School Core Electron Microscopy Facility. Cells were fixed for 10 minutes by adding 1 ml of 2.5% 
glutaraldehyde (v/v) in 0.75 M sodium phosphate buffer (pH 7.2) to each of the medium-
containing wells of the culture plate. Fixative was removed and added at full strength overnight at 
4°C. The next day the fixed samples were washed three times in 0.75 M sodium phosphate buffer 
(pH 7.2). The cells were then scraped off the bottom of the wells with a soft plastic spatula, 
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collected in a microcentrifuge tube, pelleted, briefly rinsed in deionized water, post-fixed for 1 hr 
in 1% osmium tetroxide (w/v) in deionized water, washed, and dehydrated through a graded 
series of ethanol concentration increases in 20% increments before two changes in 100% ethanol. 
Samples were then infiltrated first with two changes of propylene oxide and then a mixture of 50% 
propylene oxide / 50% SPIpon 812/Araldite epoxy resin overnight. Cell pellets were transferred 
through three changes of fresh SPIpon 812/ Araldite epoxy resin, embedded into molds filled 
with the same resin, and polymerized for 48 hrs at 70°C. The epoxy blocks were then trimmed 
and ultrathin sections were cut on a Reichart-Jung ultramicrotome using a diamond knife. The 
sections were collected and mounted on copper support grids and contrasted with lead citrate and 
uranyl acetate. The samples were examined on a FEI Tecnai 12 BT transmission electron 
microscope using 80Kv accelerating voltage. Images were captured using a Gatan TEM CCD 
camera. 
 
Statistical analysis 
Statistical analysis was performed with GraphPad Prism® 5.0. To evaluate the differences 
between two groups (cell death and BMDM cytokine release), the two-tailed t-test was used. 
When more than two groups were compared, two-way ANOVA with Tukey’s post-test was 
utilized. Differences between cytokine levels in infected mice were analyzed by the Mann-
Whitney U test. Group size for animal experiments was calculated by power analysis. Survival 
analysis was performed using the log-rank test. 
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Results and Discussions 
Yersinia induces cell death via RIP1, caspase-8 and RIP3 
Viable Y. pestis KIM5 can induce rapid cell death (Fig. 2.1A). Cell death in bone marrow-derived 
macrophages (BMDMs) is induced in a YopJ-dependent manner by Y. pestis or Y. 
pseudotuberculosis temperature-shifted from 26°C to 37°C (Fig. 2.1A,B), a condition that mimics 
the temperature change from flea temperature (26°C) to mammalian body temperature (37°C) 
which is associated with infection via a fleabite. In addition to arming the type three secretion 
system (T3SS), the temperature shift ensures the initial presence of some TLR4-stimulatory LPS 
which is hexa-acylated lipid A/LPS and is synthesized only at 26°C and not 37°C (Montminy et 
al., 2006). The TLR4-stimulatory activity of LPS synthesized by Y. pestis was measured through 
the production of cytokine IL-8 by HEK293 cells that stably express human TLR4/MD2 (Fig. 
2.1C). 
 
Y. pestis can induce inflammasome activation and caspase-1 cleavage (Lilo et al., 2008; Vladimer 
et al., 2012). As active caspase-1 induced by inflammasome activation also leads to pyroptotic 
cell death, we investigated whether Y. pestis-induced cell death is due to pyroptosis. First, the 
BMDMs were pretreated with the caspase-1 inhibitor YVAD and the results indicated that 
YVAD did not abrogate Y. pestis-induced cell death, suggesting that caspase-1 activity was not 
required in Yersinia cytotoxicity (Fig. 2.2A). Using caspase-1-/-caspase-11-/- BMDMs, it was 
further confirmed that macrophage death induced by Y. pestis was independent of caspase-1 and 
caspase-11, thus the mode of cell death is not through pyroptosis (Fig. 2.2B). In addition to 
caspase-1, the inflammasome-related NLRs, NLRP3, NLRC4 and NLRP12 are also not involved  
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Figure 2.1 Live Yersinia induces rapid cell death that is dependent on YopJ and Y. pestis 
shows TLR4-stimulating activity when grown at different temperatures. 
 (A) BMDMs were stimulated with the indicated Yersinia strains (MOI 40) for 4 h, and cell death 
was determined by LDH assay. BMDMs were killed by Y. pestis and Y. pseudotuberculosis, but 
not by bacteria lacking the T3SS effector YopJ. (B) C57Bl/6 or 129xC57Bl/6 F2 immortalized 
macrophages were infected with live Y. pestis, Y. enterocolitica (MOI 40), Salmonella (MOI 1.5), 
or heat killed (56°C, 2 h) Y. pestis (equivalent to MOI of 40) for the indicated time points. Cell 
death is comparable between C57Bl/6 cells and 129 x C57Bl/6 F2 macrophages. (C) HEK293 
cells that stably express human TLR4/MD2 were stimulated with heat-killed Y. pestis KIM5 
(MOI 10) for 18 h. KIM5 37°C bacteria were grown continuously at 37°C, and KIM5 26°C were 
grown continuously at 26°C before being heat-killed. IL-8 in supernatant was detected by ELISA. 
Figures are representative for 3-8 experiments performed. Bars indicate mean plus SD. **p<0.01, 
*p<0.05 (two-tailed t-test)  
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Figure 2.2 Yersinia-induced macrophage death does not require caspase-1, caspase-11, 
NLRP3, NLRC4, NLRP12, IL-1β, IL-18 or ASC. 
A-D) BMDMs were infected with Y. pestis, Y. pseudotuberculosis (MOI 40) or Salmonella (MOI 
1.5) for 4 hrs as indicated.  In (A) cells were pretreated for one hr prior to infection with 20 µM of 
the pan-caspase inhibitor zVAD-fmk or the caspase-1 inhibitor YVAD-fmk. Cell death was 
determined by measuring LDH release into the supernatant. Figures are representative for 3-5 
experiments performed. Bars indicate mean plus SD. *p<0.05 (two-tailed t-test) 
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in Y. pestis-induced cell death (Fig. 2.2C). Similarly, deficiency of the inflammasome adaptor 
ASC, cytokines IL-1β or IL-18 failed to influence the cytotoxicity of Y. pestis, again confirming 
that Y. pestis-induced cell death is not inflammasome-related pyroptosis (Fig. 2.2D). Although the 
RNA-dependent protein kinase (PKR) has been suggested to contribute to Yersinia 
pseudotuberculosis-induced cell death (Hsu et al., 2004), our results demonstrate that Y. pestis- 
induced cell death between wild type and PKR-/- BMDMs is comparable (Fig. 2.3A). The 
difference might be due to the use of different cell types, different bacterial strains and infection 
conditions. Additionally, Y. pestis-induced cell death was unaffected by a deficiency in Fas ligand 
(FasL), TNF-α, or IFNabR, indicating that those death receptor-mediated cell death pathways are 
not involved (Fig. 2.3BC), which is consistent with previous studies with Y. enterocolitica YopP 
(Gröbner et al., 2007a). Therefore, although Y. pestis can induce TNFα production, cell death 
induced is not due to the cytotoxicity outcome of autocrine TNFα production.  
 
Pretreatment of BMDMs with the pan-caspase inhibitor zVAD-fmk partially inhibits Y. pestis-
induced cell death (Fig. 2.2A), suggesting the involvement of caspases other than caspase-1. It 
has been shown that Yersinia YopJ/YopP induces the activation and processing of several 
caspases, including caspase-8, -3 and -7 (Denecker et al., 2001; Gröbner et al., 2007a; Monack et 
al., 1998). Caspase-8 is a key initiator caspase in extrinsic apoptosis induced by death receptors 
and some viruses (Oberst and Green, 2011), and its activation leads to the processing of the 
executioner caspases, caspase-3 and -7. Caspase-8 deficiency results in embryonic lethality, but 
mice deficient in both caspase-8 and RIP3 (RIP3-/-caspase-8-/- mice, DKO) are rescued (Kaiser et 
al., 2011; Oberst et al., 2011). These studies indicate a vital role for caspase-8 in suppressing 
necroptosis by targeting components of the RIP3-mediated necrosis pathway (Kaiser et al., 2011; 
Oberst et al., 2011). The availability of RIP3-/-caspase-8-/- mice makes it possible to study the 
outcome of genetic deficiency of caspase-8 in different diseases or microbial infections. To 
investigate whether caspase-8 is required for Y. pestis-induced cell death, we used macrophages 
from RIP3-/-caspase-8-/- mice, which were remarkably resistant to cell death induced by Y. pestis  
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Figure 2.3 TNFα, IFNαβR1, FasL or PKR are dispensable for Yersinia-induced macrophage 
death.  
A-C) BMDMs were infected with Y. pestis, Y. enterocolitica, Y. pseudotuberculosis (MOI 40) or 
Salmonella (MOI 1.5) for 4 hrs as indicated. Cell death was determined by measuring LDH 
release into the supernatant. Figures are representative for 3 experiments performed. Bars indicate 
mean plus SD.  
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and Y. pseudotuberculosis, but not by Salmonella which induces pyroptotic cell death (Miao et al., 
2010), or by the NLRP3 inflammasome-specific trigger nigericin (Fig. 2.4AB). Although 
previous studies suggested that Yersinia-infected cells exhibit both apoptotic and necrotic 
properties, in contrast to RIP3-/-caspase-8-/- macrophages, RIP3-deficient cells are not protected 
from YopJ-induced cell death (Fig. 2.4AB). This finding suggests that Y. pestis-induced cell 
death is likely not necroptosis or that necrosis mediated by RIP3 is suppressed when caspase-8 is 
present. Electron microscopy revealed that macrophages infected with Y. pestis displayed features 
consistent with apoptotic death, such as membrane blebbing, nuclear condensation and 
fragmentation. These effects were absent in RIP3-/-caspase-8-/- macrophages which are visibly 
infected with intracellular Y. pestis (white arrows, Fig. 2.4C). Moreover, infection of 
macrophages led to DNA fragmentation patterns which are typically associated with apoptosis, 
and this fragmentation was blocked by zVAD pan-caspase inhibition (Fig. 2.4D). Taken together, 
these data strongly suggest that Yersinia induces rapid macrophage death by apoptosis via 
caspase-8. Consistent with previous reports, Y. pestis induced the cleavage of caspase-8 at 2 hours 
post of infection, resulting in the production of caspase-8 p18 subunit, and this cleavage is YopJ-
dependent (Fig. 2.5A). Similar results were observed by quantitatively measuring caspase-8 
enzymatic activity. Wild type Y. pestis induced robust caspase-8 activation while the YopJ mutant 
strain did not (Fig. 2.5B). The strong caspase-8 activity induced by Y. pestis was approximately 
50% lower in RIP3-/-caspase-8+/- macrophages compared with wild type cells, and caspase-8 
activation was completely abrogated in RIP3-/-caspase-8-/- macrophages (Fig. 2.5C). This data is 
in agreement with the genetic deficiency of caspase-8 in these cells, indicating that this caspase-8 
enzyme assay is a reliable and consistent approach to quantitatively detect the activation and 
enzymatic activity of caspase-8 (Fig. 2.5C). In most, but not all situations, RIP3-mediated 
necroptotic death also requires RIP1 (Cho et al., 2009; Moquin and Chan, 2010; Zhang et al., 
2009), a serine/threonine kinase that also contributes to NF-κB signaling 
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Figure 2.4 Caspase-8-RIP3 deficient macrophages are protected against Y. pestis-induced 
cytotoxicity. 
 (A-B) Caspase-8-/- RIP3-/- (DKO), but not RIP3 KO BMDMs are protected from Yersinia-
induced cytotoxicity measured by LDH release assay or C) electron microscopy. Bar=2µm. 
White asterisks: bacteria. D) WT immortalized macrophages were treated with zVAD (20 μM) 
for 1 hr before Y. pestis infection (MOI 40, 3 h). A Calbiochem Suicide-track DNA ladder 
isolation kit was used to detect DNA fragmentation according to the manufacturer’s instructions. 
BMDMs were infected with 10-40 multiples of infection (MOI) of Yersiniae or 1.5 MOI of S. 
typhimurium for 4 hrs (A,B) or 2 hrs (C), and gentamycin was added after 1 hr. Figures are 
representative for 3-8 experiments performed. Bars indicate mean plus SD. **p<0.01 (two-tailed 
t-test) 
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Figure 2.5 Y. pestis induces caspase-8 cleavage and activation, which is dependent on the 
presence of YopJ. 
 (A-B) C57Bl/6 BMDMs were infected with Y. pestis or Y. pestis ΔYopJ (MOI 40) for indicated 
time points (A) or 2 hrs (B). The cleavage of caspase-8 was detected by western blot (A) and the 
caspase-8 activation by Caspase-Glo 8 assay (B). (C) BMDMs were infected with Y. pestis (MOI 
40) for 2 hrs and the caspase-8 activity was measured by Caspase-Glo 8 assay. Figures are 
representative for 3-5 experiments performed. Bars indicate mean plus SD.  
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(Cusson-Hermance et al., 2005) and apoptosis (Christofferson et al., 2014). RIP1 is a critical 
regulator and decision checkpoint for TNF-induced NF-κB activation, apoptosis or necrosis 
through its kinase and scaffolding activities (Festjens et al., 2007). In addition to death receptors, 
RIP1 also regulates cell survival and death fate decisions downstream of TRIF through RHIM 
domain interactions between TRIF and RIP1 when responding to TLR3 or TLR4 ligands 
(Feoktistova et al., 2011). Grobner et al. suggested the potential involvement of RIP1 in the cell 
death induced by Y. enterocolitica YopP (Gröbner et al., 2007a). We therefore investigated the 
potential requirement of RIP1 in Y. petsis-induced cell death. RIP1-/- mice die shortly after birth 
(Kelliher et al., 1998), but fetal liver macrophages from RIP1-/- mice, in contrast to RIP3-/- 
macrophages, displayed a complete rescue from cell death induced by Y. pestis (Fig. 2.6A). 
Furthermore, DNA fragmentation induced by Y. pestis infection, was absent in RIP1-/- fetal liver 
macrophages (Fig. 2.6B). A novel, potent and specific inhibitor of RIP1 kinase activity, has 
recently been identified (P.A.H., J.B., P.J.G., manuscript in preparation). The RIP1 inhibitor 
GSK’963, but not the inactive enantiomer GSK’962, blocks Y. pestis-induced cell death (Fig. 
2.6C). Taken together, the results by both genetic evidence and pharmaceutical inhibitor suggest 
that RIP1 is also required for Y. pestis-induced apoptotic cell death.  Since RIP1 has been 
suggested to interact with caspase-8 and FADD to mediate the apoptosis induced by TNF, or 
cIAP inhibitors (Bertrand and Vandenabeele, 2011; Tenev et al., 2011; Vince et al., 2007), we 
therefore propose that RIP1 and caspase-8 are involved in the same pathway to mediate Y. pestis-
induced apoptosis. To evaluate this hypothesis, we used co-IP to detect the Y. pestis-induced 
interaction between RIP1 and caspase-8 (Fig. 2.6D). Y. pestis ΔYopJ failed to induce the 
interaction of RIP1 and caspase-8, consistent with the inability of the YopJ mutant strain to 
induce cell death (Fig. 2.1A). In addition, Y. pestis-induced robust caspase-8 enzymatic activation 
was totally suppressed in RIP1-/- cells or significantly decreased by RIP1 kinase inhibitor 
GSK’963 pretreatment (Fig. 2.7AB). Accordingly, the cleavage of caspase-8 was also inhibited in 
RIP1-/- macrophages (Fig. 2.7C), suggesting that RIP1 might function upstream of caspase-8 and 
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Figure 2.6 RIP1 inhibition or deficiency protects macrophages from Y. pestis-induced cell 
death. 
 (A-B) RIP1-deficient fetal liver macrophages are resistant to Y. pestis-induced apoptotic death 
(MOI 40, 4h), determined by LDH release (A) or DNA fragmentation assay (B).  C) WT 
BMDMs were treated with the RIP1 inhibitor GSK’963 or inactive control compound GSK’962 
or vehicle control DMSO for 1 h before Y. pestis infection (MOI 40, 4 h), then cell death was 
detected by LDH assay. D) RIP1 forms a complex with caspase-8 upon infection (1 h), measured 
by co-IP. Asterisk: IgG heavy chain. Figures are representative for 3-4 experiments performed. 
Bars indicate mean plus SD. **p<0.01 (two-tailed t-test) 
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Figure 2.7 Y. pestis-induced caspase-8 activation or cleavage is inhibited in RIP1 deficient 
fetal liver macrophages or by RIP1 inhibitor. 
A, C) Fetal liver macrophages were infected with Y. pestis (MOI 40, 2 h). B) C57Bl/6 BMDMs 
were pretreated with RIP1 inhibitor GSK’963 for 1 h before Y. pestis infection (MOI 40, 2 h). 
Then the caspase-8 activity was measured by Caspase-Glo 8 assay (A, B) or the cleavage of 
caspase-8 was detected by Western blot (C). Shown is representative of three performed 
experiments. Bars indicate mean plus SD. **p<0.01 (two-tailed t-test) 
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regulate caspase-8 activation to trigger apoptosis.  
 
Previous reports indicate that TLR4-/- BMDMs are partially protected from Yersinia-induced 
cytotoxicity (Gröbner et al., 2007b; Zhang and Bliska, 2003). Downstream of TLR4, TRIF-/- 
BMDMs show a similar protective effect as TLR4 deficient cells. In contrast, MyD88-/- BMDMs 
exhibit cell death similar to wild type cells (Fig. 2.8B). TLR4 signaling can also induce 
necroptosis when cells are treated with zVAD-fmk to inhibit caspase-8 via a TRIF- and RIP3-
dependent pathway (He et al., 2011; Kaiser et al., 2013). Our data supports the conclusion that 
LPS plus zVAD induced a RIP3-dependent necrosis in macrophages (Fig. 2.8A). In addition, 
heat-killed Y. pestis showed a similar effect as LPS to induce RIP3-dependent necrosis when 
combined with zVAD to stimulate cells (Fig. 2.8A). Moreover, RIP1-/- fetal liver macrophages 
were also protected from necroptotic cell death induced by LPS plus zVAD or heat killed 
Yersinia plus zVAD (Fig. 2.8A). To further investigate the role of the TLR4 signaling pathway, 
we infected TLR4-/-, TRIF-/- or MyD88-/- BMDMs with Y. pestis (MOI 40) for 4 hours and 
detected LDH released from dying cells. In agreement with studies by other groups (Gröbner et 
al., 2007b; Zhang and Bliska, 2003), Y. pestis-induced BMDM death is partially dependent on 
TLR4 and TRIF, but not MyD88 (Fig. 2.8B). RIP1 kinase inhibition by GSK’963 further 
suppressed the remaining cell death of TLR4-/- and TRIF-/- BMDMs (Fig. 2.8B), suggesting that 
RIP1 contributes to both TLR4-TRIF-mediated and TLR4-TRIF-independent cell death pathways. 
Accordingly, cleavage of caspase-8, as well as caspase-8 activation, was impaired in TLR4- and 
TRIF-deficient BMDMs but not in MyD88-deficient cells (Fig. 2.8CD). Reduced cell death in 
TRIF-/- BMDMs was also seen for bacteria grown at 37°C and Y. pestis-EcLpxL, which 
constitutively generates a hexa-acylated LPS even when grown at 37°C (Fig. 2.9B). Based on 
these results, TLR4-TRIF signaling appears to not be absolutely required, but enhances caspase-8 
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Figure 2.8 Y. pestis-induced macrophage death, caspase-8 cleavage and activation partially 
require TLR4 and TRIF but not MyD88. 
A) Necroptosis induced by zVAD (20 μM) plus LPS (50 ng/mL) or zVAD plus heat-killed Y. 
pestis KIM5 (equal to MOI 10) (18 h stimulation) is greatly decreased in RIP3−/− BMDMs or 
RIP1−/− fetal liver macrophages. B-D) BMDMs from WT, TLR4-/-, TRIF-/- or MyD88-/- mice were 
infected with Y. pestis (MOI 40) for 2 (C,D) or 4 hrs (B).  In (B), cells were pretreated for 1 hour 
before infection with the RIP1 inhibitor GSK’963.  Supernatants were assayed for LDH release to 
determine cell death. Caspase-8 cleavage by Western blot (C) and caspase-8 activity by Caspase-
Glo 8 assay (D).  B) Y. pestis-induced BMDM death is partially dependent on TLR4 and TRIF 
but not MyD88 that is further reduced when RIP1 is inhibited.  C) Cleavage of caspase-8 is 
impaired in TLR4- and TRIF-deficient BMDMs but not in MyD88-/- BMDMs.  D) Caspase-8 
activity induced by Y. pestis is impaired in TLR4- and TRIF-deficient BMDMs but not in 
MyD88-/- BMDMs. Shown is representative of three performed experiments. Bars indicate mean 
plus SD. **p<0.01 (two-tailed t-test) 
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-mediated apoptosis by Y. pestis YopJ, similar to that proposed for Y. enterocolitica YopP  
(Gröbner et al., 2007b; Haase et al., 2003; Zhang and Bliska, 2003). 
 
We also evaluated other mutant strains of Y. pestis previously made by our group to determine 
whether they utilize the same cell death pathway as wild type Y. pestis. As shown in Fig. 2.9A, 
the Y. pestis-EcLpxL strain, which stably expresses E. coli LpxL and thus synthesizes stimulatory 
LPS at 37°C (Montminy et al., 2006), triggers a RIP3/caspase-8-dependent cell death similar to 
wild type Yersinia. The assembly of the T3SS injectisomes occurs only at 37°C and the activation 
of T3SS to translocate the Yop effectors into host cells requires bacteria and host cell contact. 
However, when Y. pestis is grown continually at 37°C, it produces a protein “capsule” F1 antigen 
to inhibit phagocytosis thus preventing its contact with the host cell (Du, 2002; Liu et al., 2006).  
Accordingly, Y. pestis which continuously grown at 37°C failed to induce robust cell death as the 
temperature-shifted bacteria even with the presence of potent LPS by expressing E.coli LpxL (Fig. 
2.9B). However, all the bacteria with different growth conditions triggered a decreased cell death 
in TRIF-/- macrophages (Fig. 2.9B), suggesting they induce cytotoxicity via the same mechanisms. 
Although cell death induced by Y. pestis grown at 37°C was inhibited by the presence of CaF1 
capsule protein, the mutation of caf gene to destroy the expression of this capsule restored 
bacterial capability to induce cytotoxicity (Fig. 2.9C). This result suggests that close contact 
between bacteria and host cells, which can be prevented by the capsule, is required for 
cytotoxicity. Similar as the E.coli LpxL expressing strain, this Y. pestis Δcaf mutant grown at 
37°C also induced a RIP3/caspase-8-dependent cell death (Fig. 2.9D).  
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Figure 2.9 Y. pestis expressing E.coli LpxL strain (Y. pestis-EcLpxL) which produces potent 
LPS also induces RIP3/Caspase-8 dependent cell death as wild type Y. pestis.  A capsule-
deficient strain of Y. pestis triggers RIP3/Caspase-8 dependent death when bacteria are 
grown at 37°C. 
A-B) BMDMs were infected with Y. pestis KIM5, or KIM5-EcLpxL grown at 37°C (B) or grown 
as our normal shift rationale (A) for 4 hrs. Then LDH release was detected.   C-D) Immortalized 
mouse macrophages were infected with wild type Y. pestis or Y. pestis Δcaf1 (F1 antigen, protein 
capsule) grown at 37°C (MOI 40).  C) Caf1 deficiency enables Y. pestis grown at 37°C to induce 
cytotoxicity, in contrast to wild type bacteria.  D) RIP3-/-caspase-8-/- immortalized macrophages 
are resistant to Y. pestis Δcaf1-induced cytotoxicity.  Cell death was measured by LDH release 
into the supernatant. Figures are representative for three experiments performed. Bars indicate 
mean plus SD. *p<0.05 **p<0.01 (two-tailed t-test) 
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Y. pestis-induced cell death is completely inhibited in RIP3-/-caspase-8-/- macrophages, but is not 
affected in RIP3-deficient cells, suggesting that the cell death is mediated via caspase-8. 
Therefore, caspase-8 deficient cells should demonstrate a similar phenotype to RIP3-/-caspase-8-/- 
macrophages. To address this, caspase-8 conditional knockout (CKO) macrophages resulting 
from the targeted deletion of caspase-8 in myeloid cells (caspase-8 fl/fl LysM cre+/+ generated by 
D. Shayakhmetov) were used. The deficiency of caspase-8 in these conditional knockout cells 
was confirmed by detecting the expression level and enzyme activity of caspase-8 upon Y. pestis 
infection (Fig. 2.10AB), and showed very little caspase-8 remaining in these CKO BMDMs (Fig. 
2.10A). Interestingly, in comparison with RIP3-/-caspase-8-/- macrophages, caspase-8 deficiency 
alone had little effect on Y. pestis-induced macrophage death (Fig. 2.10C). Although the 
generation of other mice with defects in caspase-8 in macrophages has been reported (Kang et al., 
2004), our caspase-8 CKO BMDM appeared healthy in culture and did not display increased cell 
death in the absence of infection (data not shown). GSK’872 is a recently defined potent RIP3 
inhibitor to specifically inhibit RIP3 kinase activity (Kaiser et al., 2013). Blockade of RIP3 kinase 
activity with GSK’872 strongly reduced cell death in caspase-8 CKO macrophages, but had no 
impact on wild type BMDMs, suggesting that deletion of caspase-8 may promote necroptosis by 
RIP3 (Fig. 2.10D). As illustrated in our previous results, caspase-8 inhibition by the pan-caspase 
inhibitor zVAD sensitizes macrophages to RIP1- and RIP3-dependent necropsis in response to 
LPS or heat killed bacteria (Fig. 2.8A). Taken together, we propose that RIP1-caspase-8-mediated 
apoptosis is the dominant type of cell death induced by Yersinia YopJ; however, when caspase-8 
is deleted or inhibited, RIP3-mediated necroptosis will be unblocked. The inhibitory role of 
caspase-8 to block necroptosis has been well characterized (Kaiser et al., 2011; Oberst et al., 
2011). For the underlying mechanism, it was proposed that caspase-8 inhibits RIP3-mediated 
necroptosis through cleaving RIP1 and RIP3 to separate their kinase domains from the RHIM  
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Figure 2.10 Caspase-8 conditional KO (CKO) macrophages are not protected from Y. pestis-
induced cell death. 
A) Western blot of BMDMs from the caspase-8 conditional knock-out mouse show a significant 
reduction in caspase-8 expression.  B)  BMDMs from the conditional caspase-8 knockout mouse 
infected with Y. pestis (MOI 40) for 2 hours show reduced caspase-8 activity compared to WT 
cells, using the Caspase-Glo 8 assay. C) BMDMs were treated with Y. pestis (MOI 8, 9 hrs) or 
zVAD (20 µM) plus LPS (100 ng/mL) for 10 hrs. zVAD plus LPS can induce necroptosis,  which 
is inhibited when RIP3 is deficient. But in caspase-8 conditional knockout macrophages, the 
necroptosis induced by zVAD and LPS is significantly increased than wild type cells. Y. pestis-
induced cell death is blocked in RIP3-/-caspase-8-/- BMDMs but not caspase-8 CKO macrophages. 
D) Caspase-8 CKO macrophages are protected from Y. pestis (MOI 40, 4 hrs) induced death in 
the presence of RIP1 (GSK’963) or RIP3 (GSK’872) kinase inhibitors, but not by inactive control 
compound GSK’962. E) RIP1 is cleaved following Y. pestis infection (MOI 40, 2 hrs) in a 
caspase-8 dependent fashion. Figures are representative for three experiments performed. Bars 
indicate mean plus SD. **p<0.01 (two-tailed t-test) 
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domains (Chan et al., 2003; Feng et al., 2007). Consistent with this proposal, Y. pestis induced 
obviously RIP1 cleavage, which was reduced when caspase-8 was absent (Fig. 2.10E).  
As shown in Fig. 2.11A, cleavage and activation of the downstream apoptotic executioner 
caspase-3 was dependent upon YopJ and caspase-8–RIP3. The caspase-8–RIP3 pathway also 
influenced cell death induced by Y. enterocolitica but not by Salmonella or Pseudomonas, which 
also harbor a T3SS (Fig. 2.11B). Thus, all human pathogenic Yersiniae, but not all bacteria 
containing a T3SS, trigger cell death via the same pathway. Our results provide an explanation 
for how Yersinia induces macrophage cell death via caspase-8 and RIP kinases. In this model, 
caspase-8-dependent apoptosis represents the default pathway, while the absence of caspase-8 
may lead to RIP3-dependent necroptosis. RIP1 has a key upstream role for both modes of cell 
death, perhaps influenced by its ability to direct apoptosis under conditions of cIAP1 depletion 
(Feoktistova et al., 2011; Tenev et al., 2011), also seen with Y. pestis infection (Fig. 2.11C).  
 
Effects on NF-κB activity 
As indicated in Fig 2.12AB, we observed a significant reduction in TNFα and IL-6 release in 
RIP3-/-caspase-8-/-, but not in RIP3-/- macrophages upon Yersinia infection or LPS stimulation. 
However, cytokine production induced by the TLR2 ligand Pam3Cys (Fig. 2.12A,B) or Sendai 
virus (Fig. 2.12C) was not significantly altered in RIP3-/-caspase-8-/- macrophages. In addition, 
IL-1β transcription as well as pro-IL-1β expression, were also attenuated in RIP3-/-caspase-8-/- 
macrophages but not in RIP3-/- cells (Fig. 2.12DE). The synthesis of TNFα, IL-6 and pro-IL-1β  
are all regulated by the NF-κB pathway. Caspase-8 has been suggested to have non-apoptotic 
roles, one of which is to regulate NF-κB activity (Kang et al., 2008; Man et al., 2013; Su et al., 
2005). Caspase-8 is required for NF-κB activation by antigen receptor and LPS stimulation, but  
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Figure 2.11 Y. pestis induced caspase-3 cleavage and cIAP1 depletion and the cell death 
triggered by Pseudomonas aeruginosa is not mediated by RIP3 and caspase-8. 
A) Wild type or RIP3-/-caspase-8-/- immortalized mouse macrophages were infected with wild 
type bacteria or Y. pestis ΔYopJ for 2.5 hrs and caspase-3 was determined in cell lysates by 
Western blot.  Cleavage and activation of caspase-3 induced by Y. pestis is dependent upon YopJ 
and absent in RIP3-/-caspase-8-/- macrophages. B)  Wild type or RIP3-/-caspase-8-/- immortalized 
mouse macrophages were infected with Y. enterocolitica (MOI 20) or Pseudomonas aeruginosa 
(MOI 40) for 4 hrs. Cell death was determined by measuring LDH in the supernatant.  C)  Wild 
type immortalized macrophages were infected with Y. pestis for the indicated time points and 
gentamycin was added at time points beyond 1 hr. Western blot was used to detect the Y. pestis-
induced degradation of cIAP1 during infection.  Figures are representative for three experiments 
performed. Bars indicate mean plus SD. **p<0.01 (two-tailed t-test) 
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Figure 2.12 The release of cytokines and pro-IL-1β transcription and synthesis induced by Y. 
pestis are impaired in RIP3-/-caspase-8-/- macrophages. 
A-B) Wild-type (WT) or mutant BMDMs were infected with Y. pestis, Y. pseudotuberculosis 
(MOI 10) or Salmonella (Sal, MOI 1.5)  or treated with LPS (100 ng/mL) or Pam3Cys (500 
ng/mL) for 6 hrs, and cytokine release was measured by ELISA. C) Immortalized macrophages 
were infected with Y. enterocolitica (MOI 10) or Sendai Virus (200 pfu) for 20 hrs. TFNα 
production was detected by ELISA. D) BMDMs were infected with Y. pestis for 4 hrs, mRNA 
was isolated and qPCR for pro-IL-1 was performed. E) BMDMs were infected with Y. pestis or 
Y. pestis ΔYopJ (MOI 10) for 6 hrs and pro-IL-1 was detected in the cell lysates through 
Western blot. Figures are representative for 3-8 experiments performed. Bars indicate mean plus 
SD. **p<0.01 (two-tailed t-test) 
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not by TNFα in T cells, B cells or NK cells (Su et al., 2005). The cytokine reduction in RIP3-/-
caspase-8-/- macrophages suggests that the NF-κB pathway is affected by the deficiency of RIP3 
and caspase-8 in response to Yersinia or LPS, but not by TLR2 ligands or Sendai virus. To 
directly evaluate whether NF-κB activation by Yersinia is attenuated in RIP3-/-caspase-8-/- 
macrophages, we detected the different components of NF-κB pathway respectively. Since YopJ 
can inhibit NF-κB activation (see Chapter I), we stimulated wild type, RIP3-/- and RIP3-/-caspase-
8-/- macrophages with the Y. pestis ΔYopJ mutant strain or LPS for indicated time points as shown 
in Fig. 2.13.  First, p65 nuclear translocation was decreased in RIP3-/-caspase-8-/- macrophages at 
40 and 60 minutes after LPS stimulation (Fig. 2.13A). Next, we detected the phosphorylation of 
IκBα, which leads to its own degradation and thus releases the p65 to translocate into nucleus. 
Upon Y. pestis ΔYopJ or LPS stimulation, the phosphorylation of IκBα was reduced in RIP3-/-
caspase-8-/- macrophages compared with wild type cells (Fig. 2.13BC). Accordingly, the 
degradation of IκBα in DKO macrophages was impaired at later time points (30 or 45 minutes) 
after adding bacteria or LPS (Fig. 2.13BC). IκBα degradation induced by TNFα stimulation was 
not affected in DKO cells (Fig. 2.13D), suggesting that the deficiency of caspase-8 and RIP3 does 
not affect NF-κB activation by all stimuli, which is consistent with a previous report (Su et al., 
2005). IKKα/β is the upstream kinase responsible for phosphorylating IκBα and phosphorylation 
of IKKα/β leads to its activation. As shown in Fig. 2.13E, the phosphorylation of IKKα/β induced 
by LPS was also suppressed in RIP3-/-caspase-8-/- macrophages, suggesting that the defect is 
located upstream of IKKα/β. The cytokine production, as well as IκBα degradation was intact in 
RIP3-/- cells in contrast to RIP3-/-caspase-8-/- macrophages, suggesting that caspase-8 contributes 
to NF-κB activation. Similar to DKO cells, IL-6 release induced by Y. pestis was significantly 
decreased in caspase-8 CKO macrophages (Fig. 2.13F), indicating that the attenuation of NF-κB  
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Figure 2.13 NF-κB signaling pathway is attenuated in RIP3-/-caspase-8-/- macrophages. 
A) Immortalized macrophages were stimulated with LPS (100 ng/mL) for the indicated time 
points. Nuclear extracts were probed by immunoblot for p65 and Histone-3. B-E) BMDMs were 
infected with Y. pestis ΔYopJ (MOI 10) or treated with LPS (100 ng/mL), mouse TNFα 
(10ng/mL, 10 min), and cell lysates were probed by immunoblot for the indicated proteins (IκBα, 
phospho-IκBα, phospho-IKKα/β, IKKα or β-actin). F) Wild type or caspase-8 CKO macrophages 
were infected with Y. pestis (MOI 10) for 6 hours and IL-6 secretion in the supernatant was 
measured by ELISA. Figures are representative of 2-5 experiments performed. Bars indicate 
means plus SD. *p<0.05 (two-tailed t-test) 
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activation in the DKO cells are due to the deficiency of caspase-8 and not the dual deletion of 
both RIP3 and caspase-8. 
 
RIP1 is involved in NF-κB activation induced by TNF-α, TLR4 and TLR3 signaling (Cusson-
Hermance et al., 2005; Hsu et al., 1996). In our model of Yersinia infection, reduced IL-6 
production could also be observed in RIP1-/- fetal liver macrophages (Fig. 2.14A). In addition, 
IκBα degradation was attenuated in RIP1-deficient macrophages and showed a similar 
degradation pattern to RIP3-/-caspase-8-/- cells and the IκBα degradation at later time points of 30 
and 45 min upon LPS treatment was inhibited (Fig. 2.14BC). How caspase-8 regulates NF-κB 
activation is currently unclear and may not require the self-processing of caspase-8 (Kang et al., 
2008). Our results indicate that the caspase-8 inhibitor IETD did not affect NF-κB-mediated IL-6 
production (Fig. 2.14D). However, TRIF mediated pathways may be targeted since MyD88-
dependent TLR2 signaling is not affected in RIP3-/-caspase-8-/- cells. RIP1 has been suggested to 
interact with TRIF through their RHIM domains to transduce signaling to activate NF-κB 
(Cusson-Hermance et al., 2005), and since RIP1-/- cells showed a similar IκBα degradation pattern 
to RIP3-/-caspase-8-/- cells that the later time points were influenced, caspase-8 might also affect 
TRIF-mediated late phase of NF-κB activation. 
 
RIP1, caspase-8 and RIP3 mediate inflammasome activation 
In addition to IL-6 and TNFα, we also observed that release of the cytokines IL-1β and IL-18 was 
significantly inhibited in RIP3-/-caspase-8-/- macrophages but not in RIP3-/- cells when stimulated 
by Y. pestis (Fig. 2.15AB). However, IL-1β release following stimulation with Pam3Cys and 
nigericin was intact in RIP3-/-caspase-8-/- macrophages (Fig. 2.15A), implying that not all 
universal IL-1β production machinery were affected, like the canonical NLRP3 activation herein  
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Figure 2.14 RIP1 also contributes to cytokine release and NF-κB activation induced by Y. 
pestis or LPS. 
A) WT or RIP1-/- fetal liver macrophages were stimulated with LPS (50 ng/mL), Pam3Cys (500 
ng/mL), Y. pestis (MOI 10) or Salmonella (MOI 1.5) for 6 hrs. IL-6 release was measured by 
ELISA. B-C) Fetal liver macrophages (B) or immortalized macrophages (C) were stimulated with 
LPS (100 ng/mL) for the indicated time points. The IκBα degradation in cell lysates was detected 
by Western blot.  C) In RIP3-/-Casp8-/- macrophages, the IκBα degradation was affected at 30 min 
and 45 min, but not at early 15 min time point, when compared with WT macrophages. D) 
Caspase-8 enzymatic inhibitor IETD (40 µM) doesn’t affect Y. pestis-induced IL-6 production. 
Figures are representative for three experiments performed. Bars indicate mean plus SD. 
**p<0.01 (two-tailed t-test) 
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triggered by Pam3Cys and nigericin.  As suggested previously (Lilo et al., 2008; Vladimer et al., 
2012), Y. pestis-induced IL-1β and IL-18 production is dependent on YopJ,  since Y. pestis 
ΔYopJ mutant infection did not trigger any detectable IL-1β secretion (Fig. 2.15A,B). IL-1β 
production was partially decreased in caspase-8 CKO macrophages, in contrast to complete 
inhibition in RIP3-/-caspase-8-/- DKO cells (Fig. 2.15C). RIP3 inhibition by the kinase inhibitor 
GSK’862 could further inhibit the residual IL-1β secretion in caspase-8 CKO cells (Fig. 2.15D). 
RIP1 kinase inhibitor GSK’963 pretreatment completely blocked IL-1β release induced by Y. 
pestis (Fig. 2.15D). While the absence of caspase-8 alone in macrophages decreased IL-1 
release induced by Yersinia infection, it prompted IL-1 production by LPS treatment (Fig. 
2.15E),  similarly to that suggested for caspase-8 CKO dendritic cells in which LPS alone can 
induce IL-1β production (Kang et al., 2013). This IL-1β release in caspase-8 CKO cells by LPS 
could be blocked by the RIP1 inhibitor Necrostatin-1, indicating that it is RIP1 kinase-mediated 
and shows consistency with studies by Kang et al. (2013) (Fig. 2.15E). Thus, more intricate 
stimulations, like those observed during infections, yield a different result than a purified ligand 
like LPS, possibly reflecting combined effects induced by both LPS and the Yersinia T3SS 
effector YopJ in the context of live bacteria.  
 
Our previous data (Fig. 2.12, 2.13) could partially explain reduced IL-1β release, due to the 
impairment of NF-κB activation in RIP3-/-caspase-8-/- macrophages, which contributes to the 
transcription and synthesis of pro-IL-1β. Unlike IL-6 and TNFα, the release of mature IL-1β and 
IL-18 requires additional stimuli to trigger pro-IL-1β processing into mature cytokines, normally 
mediated by active caspase-1. Although, caspase-8 is also suggested to be able to directly cleave 
pro-IL-1β independent of caspase-1 when stimulated with TLR ligands poly (I:C) or LPS 
(Maelfait et al., 2008), Fas ligand (Bossaller et al., 2012), or fungi and mycobacteria sensed by  
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Figure 2.15 Y. pestis-induced release of IL-1β and IL-18 is severely reduced in RIP3-/-
caspase-8-/- macrophages. 
A-E) BMDMs were infected with Y. pestis or Y. pestis ΔYopJ  (MOI 10) for 6 hrs, or stimulated 
with nigericin (10µg/ml) for 1 hr after priming with Pam3Cys (4 hrs, 500 ng/ml). IL-1β and IL-18 
were analyzed by ELISA. D) Some BMDMs were treated with RIP1 inhibitor GSK’963 (1 µM) 
or RIP3 inhibitor GSK’872 (10 µM) for 1hr before infection. E) BMDMs were challenged with Y. 
pestis (MOI 10) for 6 hrs or LPS (50 ng/mL) for 10 hrs with or without Nec-1 pretreatment (20 
µM).  Figures are representative of 3-5 experiments. Bars indicate means plus SD. **p<0.01, 
*p<0.05 (two-tailed t-test in A,B,C, and two-way ANOVA with Tukey’s post-test in D,E). 
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dectin-1 (Gringhuis et al., 2012). Surprisingly, caspase-8 or RIP1 inhibition minimized Y. pestis-
induced caspase-1 cleavage (Fig. 2.16AB), implying direct effects on inflammasome action by 
caspase-8 and RIP1. To address this question, we infected wild type, RIP3-/- and RIP3-/-caspase-8-
/- macrophages, or RIP1+/+ and RIP1-/- fetal liver macrophages with Y. pestis and assessed caspase-
1 processing. As shown in Fig. 2.16CD, caspase-1 cleavage induced by Yersinia was inhibited in 
RIP3-/-caspase-8-/- and RIP1-/- macrophages, but not in RIP3-deficient cells. Caspase-1 cleavage 
induced by Salmonella and Pam3Cys plus nigericin stimulation was not affected (Fig. 2.16CD), 
indicating that NLRC4- and NLRP3-mediated caspase-1 cleavage is not inherently reduced in 
RIP1-/- or DKO cells. Moreover, the pro-caspase-1 expression level in cell lysates was not 
obviously changed in RIP1-/- or RIP3-/-caspase-8-/- cells (Fig. 2.16CD), suggesting the deficiency 
of RIP1 or caspase-8/RIP3 affects the processing of pro-caspase-1 into its active, cleaved form.  
Consistent with the ELISA results of IL-1β release, Western blot also demonstrates that the 
secretion of mature IL-1β into cell supernatant by Y. pestis was inhibited in RIP3-/-caspase-8-/- 
macrophages (Fig. 2.16E).  In cell lysates of caspase-8 CKO macrophages, both cleaved caspase-
1 and mature IL-1β production were attenuated compared with wild type cells (Fig. 2.16F), 
further suggesting the involvement of caspase-8 in caspase-1 cleavage when infected with Y. 
pestis. Although we cannot exclude the possibility that caspase-8 directly cleaves pro-IL-1β 
during Y. pestis challenge, our western blot results (Fig. 2.16) propose another effect of caspase-8 
in inflammation, directly inducing caspase-1 cleavage and activation, in a RIP3-enhanced manner. 
To further investigate the underlying mechanism, we first checked the potential upstream players 
which might be involved in caspase-8 activation and the related IL-1β production. As shown in 
Fig. 2.17ABC, both IL-1β release and caspase-8 activity induced by Y. pestis was not 
significantly affected in cells deficient in TNFα, IFNabR or FasL, suggesting that caspase-8 
activation and IL-1β maturation appear independent of TNFα, type I IFN and FasL and 
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Figure 2.16 RIP kinases and caspase-8 control caspase-1 cleavage induced by Y. pestis. 
A-B) Wild type BMDMs were pretreated with inhibitors ( caspase-1 inhibitor YVAD, 20 µM; 
caspase-8 inhibitor IETD, 40 µM; pan-caspase inhibitor zVAD, 20 µM; RIP1 kinase inhibitor 
GSK’963, 1 µM; RIP3 kinase inhibitor GSK’872, 10 µM) for 1 hr before Y. pestis infection (MOI 
10, 6 hrs). The supernatants were harvested and assayed for caspase-1 processing. C-F) BMDM 
(WT, RIP3-/-, RIP3-/-caspase-8-/- DKO, caspase-8 CKO) or fetal liver macrophages (RIP1+/+, RIP1-
/-) were infected with Y. pestis, Y. enterocolitica (MOI 10)  or Salmonella (Sal, MOI 1.5) for 6 hrs 
or primed with Pam3Cys followed by nigericin or Y. pestis for 1 hr or 6 hrs, and supernatants (SN) 
or lysates (F) were analyzed for caspase-1 or IL-1β processing by immunoblots. Figures are 
representative of three experiments. 
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may have some common features with responses induced by certain drugs or Citrobacter 
(Antonopoulos et al., 2013; Gurung et al., 2014; Shenderov et al., 2014).  However, both caspase-
1 cleavage and IL-1β production stimulated by Y. pestis were obviously reduced in TLR4-/- and 
TRIF-/- macrophages (Fig. 2.17DE). In MyD88-/- macrophages, the caspase-1 processing was 
similar to wild type cells but the IL-1β release was completely abrogated, which can be attributed 
to MyD88’s critical role in the NF-κB activation pathway to induce the transcription and 
synthesis of pro-IL-1β (Fig. 2.17DE). Similar to the cell death results (Fig. 2.8BC), caspase-1 
processing in TLR4-/- and TRIF-/- cells was partially decreased unlike the complete inhibition 
observed in RIP3-/-caspase-8-/- macrophages, suggesting the pathways to regulate caspase-1 
cleavage and induce cell death have common players. TLR4-TRIF signaling is not necessarily 
required, but contributes to amplify the effects.  
 
It is unclear how caspase-8 executes the cleavage of caspase-1. Our results suggest that the 
inflammasome adaptor ASC might play a role as the caspase-1 cleavage induced by Y. pestis was 
inhibited in ASC-deficient macrophages (Fig. 2.17F). ASC can associate with caspase-8 after 
Francisella or Salmonella infection (Man et al., 2013; Pierini et al., 2012) , although  the role of  
ASC may differ depending upon conditions and source of YopJ (Brodsky et al., 2010; Vladimer 
et al., 2012; Zheng et al., 2011). 
 
Role of caspase-8 and RIP3 for in vivo resistance to bacterial infection 
The results described above suggest that caspase-8 and RIP kinases play critical roles in the 
regulation of Y. pestis induced cell death, inflammasome activation and cytokine release in vitro. 
The in vivo relevance of these findings was therefore addressed in a murine model of plague.   
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Figure 2.17 Y. pestis-induced IL-1β release or caspase-1 cleavage are reduced in TLR4-, 
TRIF- and ASC-deficient BMDMs, but not in MyD88-/-, TNF-/-, IFNαβR-/- and FasLgld 
BMDMs. 
A,B,D) BMDMs from TNF-/-, IFNαβR-/-, FasLgld, TLR4-/-, TRIF-/- and MyD88-/- mice were 
stimulated with Y. pestis (MOI 10) for 6 hours, then the IL-1β in supernatant was detected via 
ELISA. C) Caspase-8 activity induced by Y. pestis is not dependent on IFNαβR1 and FasL.  
Caspase-8 activation was detected in C57Bl/6, IFNαβR1-/- and FasLgld BMDMs which were 
infected with 40 MOI Y.pestis for 2 hrs, using Caspase-Glo 8 assay. E-F) BMDMs were infected 
with Y. pestis (MOI 10) for 6 hrs. Then the supernatants (SN) or lysates were analyzed for 
caspase-1 processing by immunoblots. Figures are representative of three experiments. 
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First, we infected wild type C57Bl/6 and RIP3-/-caspase-8-/- mice with fully virulent Y. pestis 
KIM1001 (300 cfu, s.c.). Sixty-eight hours later, spleens were harvested and homogenized for 
analysis of bacterial load. As demonstrated in Fig. 2.18A, RIP3-/-caspase-8-/- DKO mice have 
significantly higher numbers of bacteria in their spleens compared to wild type mice, strongly 
suggesting that DKO mice were more susceptible to subcutaneous infection with virulent Y. pestis. 
The LD50 of fully virulent KIM1001 via subcutaneous route in mice is very low, less than 10 cfu 
(Sodeinde et al., 1992), making it very difficult to control the infection and monitor the increased 
susceptibility in genetically modified mice. To overcome this disadvantage, we used the 
attenuated strains KIM1001-EcLpxL or KIM1001-YtbLpxL, which express E.coli lpxl or Y. 
pseudotuberculosis lpxl, respectively. These strains constitutively synthesize a TLR4-activating 
hexa-acylated LPS even at 37°C. The LD50 of these attenuated strains is greater than 1x107 
(Montminy et al., 2006). We have successfully utilized the attenuated Y. pestis strains to 
investigate the contribution of various innate immune components, such as TLR4, MyD88, 
NLRP12, IL-1β or IL-18, to the innate defensive response against bacterial infection (Montminy 
et al., 2006; Vladimer et al., 2012). In addition, the in vitro results indicated that the modified 
strain Y. pestis-EcLpxL induced caspase-8/RIP3-dependent cell death, similarly to wild type Y. 
pestis (Fig. 2.9A). Hence, to determine whether the deficiency in RIP3 and caspase-8 affect the 
survival outcome of Y. pestis infection, we infected the C57Bl/6, RIP3-/-caspase-8-/-, RIP3-/- and 
RIP3-/-caspase-8+/- mice subcutaneously with 500 cfu of KIM1001-EcLpxL and monitored the 
mice for survival. As shown in Fig. 2.18B, RIP3-/-caspase-8-/-mice were significantly more 
sensitive to infection, with all mice succumbing to disease before day 5. To analyze whether the 
deficiency of RIP3 and caspase-8 also affect the cytokine production in vivo, the mice were 
infected intravenously with 500 cfu KIM1001-EcLpxL for 42 hours, and the spleen homogenates 
and serum were collected for cytokine measurement by ELISA. Compared with uninfected 
controls, Y. pestis challenge induced obvious production of IL-1β, IL-18 and IL-6 in both spleen 
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Figure 2.18 Caspase-8 with RIP3 is critical for in vivo resistance to bacterial infection. 
A) RIP3-/-caspase-8-/- DKO or WT mice were infected s.c. with virulent Y. pestis KIM1001 (300 
CFU) for 68 hrs and spleens were analyzed for bacterial growth. B) C57Bl/6, RIP3-/-, RIP3-/-
Casp8+/- or RIP3-/-Casp8-/- mice were infected subcutaneously with an attenuated strain of Y. pestis, 
KIM1001-EcLpxL (500 cfu) and monitored for survival.  RIP3-/-Casp8-/- mice were significantly 
more sensitive to infection and all died before day 5. EcLpxL-expressing Y. pestis is an attenuated 
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strain of KIM1001 that has TLR4-activating properties and utilizes the same RIP3/Caspase-8-
dependent cell death pathway (Fig. 2.9A) making this an ideal strain for survival studies.  C-D) 
Wild type or RIP3-/-Casp8-/- mice were uninfected or infected intravenously (i.v.) with 500 cfu of 
KIM1001-EcLpxL and spleen homogenates (C) and serum (D) were collected for IL-1β, IL-6 and 
IL-18 measurement by ELISA.  In the spleen (C) cytokine levels are displayed as ng cytokine per 
g of tissue. IL-1β, IL-6 and IL-18 were significantly reduced in RIP3-/-Casp8-/- mice in both the 
spleen and serum compared to wild type animals.  Shown is a representative experiment out of 2-
3 performed. *p<0.05, **p<0.01 (Mann-Whitney U test). 
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and serum, while all the cytokine levels were significantly decreased in RIP3-/-caspase-8-/- DKO 
mice (Fig. 2.18CD), showing consistency with the in vitro results. 
 
To investigate whether the sensitivity of RIP3-/-caspase-8-/- mice is due to the hematopoietic 
originating cells, WT mice were lethally irradiated (900 rads) and received bone marrow 
transplantation (BMT) from either WT, RIP3-/-caspase-8-/-, RIP3-/- or RIP3-/-caspase-8+/- mice. Six 
weeks after bone marrow transplantation, mice were infected s.c. with 500 cfu of Y. pestis 
KIM1001-EcLpxL and monitored for survival. Similar to RIP3-/-caspase-8-/- mice, all of the BMT 
mice reconstituted with RIP3-/-caspase-8-/- bone marrow cells succumbed to infection, with a few 
DKO mice that progressed slower and died after 5 days of infection (Fig. 2.19A).  Moribund mice 
had large numbers of bacteria in their spleens compared to WT controls, suggesting that death 
occurred from uncontrolled systemic bacterial replication (Fig. 2.19B). This correlated with 
decreased IL-1β, TNFα and IL-6 cytokine levels in spleen homogenates (Fig. 2.19CDE), 
phenocopying the regular RIP3-/-caspase-8-/- DKO mice (Fig. 2.18B-D).  In addition, single-cell 
suspensions of splenocytes from i.v. infected BMT mice (500 cfu, 42 hours) were stained with 
CD11b-PE antibody to identify myeloid cells and with live/dead blue and annexin V-FITC to 
determine cell viability. As indicated in Fig. 2.20AB, single splenocytes were gated for CD11b 
expression and there was no significant difference in the percentage of CD11b+ cells between 
WT and RIP3-/-caspase-8-/- BMT mice. Of the CD11b+ cells, there was no difference in the 
frequency of dead cells (live/dead blue+, annexin V+) in the uninfected WT and RIP3-/-caspase-8-
/- mice (Fig. 2.20C). However, when subjected to Y. pestis infection, the percentage of dead cells 
(live/dead blue+, annexin V+) in CD11b-positive myeloid splenocytes was significantly lower in 
RIP3-/-caspase-8-/- BMT mice than WT controls (Fig. 2.20DE).  Furthermore, the mean  
84 
 
 
 
Figure 2.19 Deficiency of caspase-8 and RIP3 in hematopoietic compartment makes mice 
susceptible to Y. pestis infection. 
A-B) Lethally irradiated mice, subjected to bone marrow transplantation (BMT) from the 
indicated genotypes, were infected s.c. with 500 CFU of Y. pestis KIM1001-EcLpxL and 
monitored for survival (A), p<0.001 DKO vs WT (log-rank test). Spleens from moribund DKO 
BMT mice and live WT controls were analyzed for bacterial loads (B). C-E) Mice from BMT as 
above were infected i.v. with KIM1001-EcLpxL (500 CFU) for 42 hrs. Spleens were 
homogenized and analyzed for cytokines by ELISA [as cytokine/g tissue]. Shown is a 
representative experiment out of 2-3 performed. *p<0.05, **p<0.01 (Mann-Whitney U test) 
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Figure 2.20 Y. pestis infection induces more death of CD11b-positive myeloid cells in WT 
spleens than RIP3-/-caspase-8-/- spleens. 
A-F) Lethally irradiated mice, transplanted with bone marrow cells (BMT) from wild type or 
RIP3-/-Casp8-/- mice were infected i.v. with 500 CFU of Y. pestis KIM1001-EcLpxL for 42 hours.  
Single-cell suspensions were made from spleens and stained with CD11b-PE to identify myeloid 
cells and with live/dead blue and Annexin V-FITC to determine cell viability.  A)  Single cells 
were gated for CD11b expression, and there were no significant differences in the percentage of 
CD11b+ cells in wild type or RIP3-/-Casp8-/- BMT mice (B).  C) Of CD11b+ cells, there was no 
difference in the frequency of dead cells (Live/Dead blue+, Annexin V+) in the uninfected WT 
and RIP3-/-Casp8-/- BMT mice.  D-E) Y. pestis infection induced significantly more dead CD11b+ 
cells in WT than RIP3-/-caspase8-/- BMT mice.  F) The mean fluorescent intensity (MFI) of 
live/dead blue stain in CD11b+ cells was significantly higher in wild type compared to RIP3-/-
Casp8-/- mice.  Shown is a representative experiment out of two performed. **p<0.01 (Mann-
Whitney U test)  
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Figure 2.21 Liver histology suggests less controlled infection in RIP3-/-caspase-8-/- BMT mice. 
Lethally irradiated mice, transplanted with bone marrow cells (BMT) from wild type or RIP3-/-
Casp8-/- mice, were infected i.v. with 500 CFU of Y. pestis KIM1001-EcLpxL for 42 hours. 
Livers were harvested, fixed and stained with hematoxylin and eosin and subjected to microscopy 
(400x). Foci containing inflammatory cells (mostly neutrophils) are shown, with visible pockets 
containing bacteria indicated by arrows. Shown is a representative experiment out of two 
performed. 
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fluorescent intensity (MFI) of live/dead blue stain in CD11b+ cells was also significantly higher 
in WT compared with RIP3-/-caspase-8-/- BMT mice (Fig. 2.20F), suggesting that Y. pestis 
infection induced more myeloid cell death in WT spleen than RIP3-/-caspase-8-/- spleen, in 
agreement with in vitro studies. We also harvested the livers of BMT mice 42 hours after i.v. 
infection with KIM1001-EcLpxL. The liver sections were stained with hematoxylin and eosin. As 
shown in Fig. 2.21, there were visible bacteria-containing pockets in inflammatory foci in the 
livers of DKO BMT mice but not present in infected WT control mice, suggesting that RIP3-/-
caspase-8-/- BMT mice failed to suppress bacterial growth in vivo.  
Since irradiated mice that received RIP3-/-caspase-8-/- BMT behaved similarly as regular DKO 
animals, we propose that protection towards infection is mediated by cells expressing caspase-8 
and RIP3 that originate from the bone marrow. Some questions still remain with respect to certain 
details of how caspase-8 and RIP3 are involved in caspase-1 processing, although it is possible 
that ASC has a central role. Our results provide a basis for increased understanding of how 
bacterial pathogens, via their T3SS, interact with several aspects of host innate immunity through 
RIP kinases and caspase-8. The data also show how apoptosis, generally viewed as a “silent” cell 
death, can be accompanied by strong inflammatory reactions, via pathways with several common 
players. The host may have developed these pathways as an effective means of alerting cells to 
the infection. We propose that caspase-8 and RIP kinases are central regulators of cell death and 
innate immune responses to Y. pestis, and we establish a role for these components in anti-
bacterial innate immune responses. Therapies that modulate the activity of these pathways may be 
useful in the treatment of bacterial infections. 
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This thesis research has focused on the mechanisms of Y. pestis-induced cell death and innate 
immune responses. We demonstrate that RIP1, caspase-8 and RIP3 are critical host factors to 
control cell fate upon Yersinia infection. RIP1 and caspase-8 also play important roles to regulate 
innate immune responses against Yersinia stimulation, including NF-κB and caspase-1 activation 
and thereby the release of IL-6, TNFα, IL-1β and IL-18 cytokines. Consistent with our in vitro 
results, RIP3-/-caspase-8-/- (DKO) mice produce significantly lower levels of IL-6, IL-1β and IL-
18 in the serum and spleen upon infection. Infected RIP3-/-caspase-8-/- mice also have decreased 
myeloid cell death in the spleen compared with WT mice. Consequently, DKO mice are more 
sensitive to Y. pestis infection and all animals succumb quickly upon bacterial challenge with an 
attenuated Y. pestis strain.  Both in vitro and in vivo work suggest that caspase-8 and RIP kinases 
critically contribute to innate immune responses and cell death elicited by Y. pestis, thus 
providing protection against bacterial infection. Concurrently, Philip et al. published similar 
results indicating that RIP1, caspase-8 and FADD are required for Y. pseudotuberculosis YopJ-
induced cell death and caspase-1 activation (Philip et al., 2014), further corroborating the novel 
and central role of RIP1 and caspase-8 in innate immunity to control Yersinia infections. 
 
Cell death 
More than 10 years ago, Yersinia bacteria were found to induce robust and rapid cell death in 
macrophages as well as dendritic cells (DCs) through its T3SS effector YopJ/YopP (Mills et al., 
1997; Monack et al., 1997). These studies indicated that Yersinia-induced cell death mostly 
display apoptosis characteristics, although one subsequent study also observed simultaneous 
necrosis-like death morphology in DCs (Gröbner et al., 2006). Through an electron microscopy 
approach, here we demonstrate that macrophages infected with Y. pestis showed typical apoptotic 
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morphologies, with nuclear condensation and cell membrane blebbing (Fig. 2.4C). The DNA 
fragmentation pattern (Fig. 2.4D, 2.6B), which represents the hallmark of apoptosis, further 
confirms that Y. pestis induces apoptosis in wild type macrophages.  
 
RIP1, as a serine/threonine kinase, has both scaffolding (kinase-independent) and non-scaffolding 
(kinase-dependent) roles, to determine the cell fate when stimulated by death receptor ligation, 
TLR ligands, RIG-I like receptor activation or cIAPs depletion (Christofferson et al., 2014). Here 
we expanded the scope by showing that RIP1 also contributes to the regulation of cell fate 
following bacterial infection. RIP1-/- fetal liver macrophages are resistant to cell death induced by 
Yersinia infection (Fig. 2.6A and Philip et al., 2014). RIP1 kinase inhibitors, including the novel 
inhibitor GSK’963 (Fig. 2.6C) and necrostatin-1 (Philip et al., 2014), efficiently block the 
Yersinia-induced cytotoxicity. Importantly, we have also excluded the possibility that RIP1-
mediated cell death by Y. pestis is a mere secondary cytotoxicity effect induced by TNFα or Fas 
ligand, as TNFα or FasL deficient cells are sensitive to Y. pestis-induced cell death (Fig. 2.3BC). 
 
For the mechanism of how RIP1 is targeted by Yersinia YopJ to induce cell death, we currently 
have some clues. As described in Chapter I, the modification of RIP1 determines the choice of 
three distinct cellular fates downstream: NF-κB activation, apoptosis, or necrosis. When RIP1 is 
highly ubiquitinated, NF-κB will be activated to promote gene transcription and cell survival. 
When RIP1 is deubiquitinated, either apoptotic or necrotic cell death pathways will be initiated.  
cIAP1 and cIAP2 are E3 ubiquitin ligases that mediate the Lys63-polyubiuitination of RIP1 
(Bertrand et al., 2008). The ubiquitin chains of RIP1 function as docking sites, recruiting 
downstream molecules including TAK1 to activate the NF-κB pathway. TAK1 also prevents 
RIP1 to interact with caspase-8 to trigger apoptosis (Bertrand et al., 2008). Two studies have 
shown that TAK1 can be directly acetylated by Y. pestis YopJ (Paquette et al., 2012) or Y. 
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pseudotuberculosis YopJ (Meinzer et al., 2012). The acetylation of TAK1 may result in its 
inhibition, leading to the interaction between RIP1 and caspase-8 and the initiation of apoptosis.  
 
Moreover, the depletion of cIAPs promotes the formation of ripoptosome (also called complex 
IIa), a signaling platform composed of RIP1, caspase-8 and FADD that leads to caspase-8-
mediated apoptosis as well as caspase-independent RIP3-mediated necrosis (Tenev et al., 2011; 
Feoktistova et al., 2011). The ripoptosome assembly requires RIP1 kinase activity (Tenev et al., 
2011). We found that Yersinia infection induced cIAP1 depletion in a time-dependent manner 
(Fig. 2.11C) and cIAP1 degradation requires YopJ (data not shown). Our preliminary data also 
indicates that YopJ may reduce the ubiquitination of RIP1 (data not shown), suggesting that 
Yersinia YopJ may inhibit the ubiquitination of RIP1 through depleting cIAPs, thus leading to the 
interaction of RIP1 and caspase-8 (Fig. 2.6D) thereby causing apoptosis. An alternative 
mechanism could be that YopJ directly acetylates RIP1, through its acetyltransferase activity (as 
described in Chapter I), and thereby inhibits the phosphorylation and ubiquitination of RIP1. 
Actually our preliminary data suggests that the phosphorylation of RIP1 is inhibited by YopJ 
(data not shown), supporting the proposal. Both hypotheses converge on the inhibited 
ubiquitination of RIP1, which favors the formation of ripoptosome to mediate cell death pathways. 
How Yersinia YopJ targets RIP1, directly or indirectly, is very interesting and needs more work 
to elucidate the exact mechanism.  
 
Y. pestis infection induced the interaction between RIP1 and caspase-8 (Fig. 2.6D), suggesting the 
formation of ripoptosome during bacterial stimulation.  RIP1, caspase-8 and FADD are the core 
components of ripoptosome, whose formation facilitates cell death by caspase-8-mediated 
apoptosis or RIP3-mediated necroptosis when caspase-8 is inhibited. Similar to RIP1-/- cells, 
RIP3-/-caspase-8-/- and RIP3-/-FADD-/- macrophages are completely resistant to Yersinia-induced 
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cytotoxicity (Fig. 2.4, Philip et al., 2014). In the extrinsic apoptosis pathway, caspase-8 acts as the 
critical initiator caspase which can be activated by death receptor ligation (as described in 
Chapter I). The caspase-8 activation is induced by its homo-dimerization. The auto-proteolytic 
cleavage, which separates the N-terminal DED domain from its C-terminal domain, can stabilize 
the active caspase-8 (Fuentes-Prior and Salvesen, 2004; van Raam and Salvesen, 2012). Cleaved, 
active caspase-8 is comprised of the large and small subunits along with its catalytic site, to target 
its substrates including caspase-3 and caspase-7 to trigger apoptosis. During Y. pestis infection, 
caspase-8 is cleaved into 18 kDa subunit and this cleavage depends on the presence of YopJ (Fig. 
2.5A). A caspase-8 enzyme assay is a reliable method to quantitatively measure the catalytic 
activity of caspase-8, and the specificity of this assay has been confirmed using RIP3-/-caspase-
8+/- and RIP3-/-caspase-8-/- cells (Fig. 2.5C). Consistently, the caspase-8 enzymatic assay also 
indicated that wild type Y. pestis induced robust caspase-8 activation at 2 hrs post infection while 
the YopJ mutant strain did not (Fig. 2.5B). Downstream of caspase-8, caspase-3 and -7 are 
substrates of caspase-8 to mediate the execution of apoptosis. We demonstrated that caspase-3 
was cleaved upon Y. pestis infection in wild type but not in RIP3-/-caspase-8-/- macrophages (Fig. 
2.11A). However, the recent report by Philip et al. indicates that Y. pseudotuboculosis-induced 
cell death is not affected in caspase-3-/- or caspase-7-/- macrophages (FigS1, Philip et al., 2014), 
suggesting that caspase-3 and caspase-7 may play redundant roles to regulate apoptosis 
downstream of caspase-8, or that caspase-8 may have alternative substrates. Deleting both 
caspase-3 and caspase-7 simultaneously will address the question of whether these caspases play 
redundant roles. 
  
RIP3 functions as the critical regulator in necrosis (see Chapter I). Here we show that Yersinia-
induced cell death is intact in RIP3-/- macrophages, suggesting that necrosis is not the preferred 
method by Yersinia to kill cells. In a surprising contrast to RIP3-/-caspase-8-/- macrophages, Y. 
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pestis still induced obvious cell death in caspase-8 conditional knockout cells (CKO, caspase-8 
fl/fl LysM cre+/+) (Fig. 2.10CD). Although there is still a small amount of caspase-8 expression 
remaining in the CKO cells (Fig. 2.10A), the difference between RIP3-/-caspase-8-/- and caspase-8 
CKO cells suggests that RIP3 can be also involved in Y. pestis-induced cell death. In caspase-8 
deficient dendritic cells, LPS alone can promote RIP3-mediated necrosis (Kang et al., 2013). 
Through the use of genetically different mouse models, it is well accepted that caspase-8 blocks 
RIP3-mediated necrosis during normal embryogenesis and when caspase-8 is deficient, RIP3-
induced necrosis will be unblocked to cause embryonic lethality (Kaiser et al., 2011; Oberst et al., 
2011). To investigate whether the death of caspase-8 CKO macrophages is mediated by RIP3, we 
pretreated cells with specific RIP3 kinase inhibitor GSK’872. As expected, this RIP3 kinase 
inhibitor significantly reduced the death of caspase-8 CKO but not WT macrophages (Fig. 2.10D).  
Moreover, pretreatment with the pan-caspase inhibitor zVAD-fmk completely inhibits Yersinia-
induced cell death in RIP3-/-, but not WT macrophages (data not shown; Philip et al. 2014: Fig. 
2C). These results suggest that Y. pestis induces RIP1-caspase-8-mediated apoptosis under 
normal conditions and that RIP3 is not required for YopJ-induced cell death in the presence of 
caspase-8. However, when caspase-8 is lacking or is chemically inhibited, RIP3-mediated 
necrosis will be unblocked to act as an alternative option to eliminate the infected cells 
(schematic model Fig. 3.1). The occurrence of necrosis in caspase-8 CKO macrophages still 
needs to be confirmed either by morphology (electron microscopy) or by immunostaining with a 
necrosis-specific antibody, like anti-phospho-MLKL (see Chapter I).  
 
Both caspase-8 cleavage and activation induced by Y. pestis were absent in RIP1-/- fetal liver 
macrophages (Fig. 2.7A, C), suggesting that RIP1 is required for the proteolytic cleavage and 
activation of caspase-8. It has been proposed that the catalytic activity of caspase-8 may play a 
role in the suppression of necrosis through cleaving RIP1 and RIP3 (Chan et al., 2003; Feng et al., 
94 
 
 
 
Figure 3.1 Schematic model of Y. pestis-induced cell death and innate immune responses. 
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2007; Oberst et al., 2011). Our results indicate that a portion of RIP1 is cleaved by Y. pestis in 
WT but not caspase-8 deficient cells (Fig. 2.10E). These results imply a mutual interplay between 
RIP1 and caspase-8, and that they may influence the cleavage and activation of one another. 
Since the cleavage of caspase-8 is known to be caused by auto-proteolysis, we propose that Y. 
pestis infection stimulates the formation of RIP1-caspase-8-FADD complex, which brings the 
caspase-8 into their own proximity and allows its activation and auto-proteolytic cleavage. The 
active caspase-8 thereby acts on RIP1 to induce its cleavage. This hypothesis is somewhat 
supported by the RIP1 kinase inhibitor GSK’963 which inhibits caspase-8 activation induced by 
Y. pestis (Fig. 2.7B), since that the kinase activity of RIP1 is important for the ripoptosome 
assembly (Tenev et al., 2011). Although it is still possible that RIP1 can directly target caspase-8 
to induce its cleavage and activation, the underlying mechanism and the interplay between RIP1 
and caspase-8 need further investigation. 
 
NF-κB activation 
Apart from the contribution to Y. pestis-induced cell death, RIP1 and caspase-8 are also involved 
in NF-κB activation and the optimal production of NF-κB-mediated cytokines: IL-6, TNFα and 
pro-IL-1β (Fig. 2.12). RIP1 is known to regulate the NF-κB pathway when stimulated by death 
receptors, TLR3 and TLR4 ligands in a kinase-independent manner. The mechanism of RIP1 
mediating the TNFα-induced NF-κB activation has been described earlier in this chapter. For 
mediating the NF-κB activation by TLR3 or TLR4 ligands, RIP1 binds to TRIF via a homotypic 
RHIM domain interaction and is thereafter ubiquitinated to recruit TAK1 for downstream NF-κB 
signaling. Caspase-8 has also been reported to mediate NF-κB activation by LPS, antigen 
receptors, viral infections or Gram-negative bacteria such as E. coli and Salmonella (Su et al., 
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2005; Man et al., 2013; Kang et al., 2008). However, unlike RIP1, both our results and data from 
Su et al. indicate that caspase-8 is not required for TNFα-mediated NF-κB activation (Fig. 2.13D. 
Su et al., 2005). This suggests that there might be discrepancy in the mechanism of RIP1- and 
caspase-8-regulated NF-κB pathway dependent on cellular context and stimulation. The 
underlying mechanism of caspase-8-mediated NF-κB activation is currently unclear. However, 
enzymatic activity but not auto-processing of caspase-8 has been suggested to be essential to 
mediate NF-κB activation (Su et al., 2005). Caspase-8 may regulate the NF-κB pathway through 
directly targeting its specific substrates. Potential candidates include cFLIP and Cylindromatosis 
(CYLD). cFLIP (cellular FLICE-like inhibitory protein) is an enzymatically inactive paralogue of 
caspase-8, with three isoforms: cFLIPS (cFLIP short), cFLIPL (cFLIP long) and cFLIPr (cFLIP 
Raji) (Irmler et al., 1997; Yu and Shi, 2008). Caspase-8 is able to cleave cFLIPL at Asp376 to  
generate N-terminal p43FLIP, which interacts with TRAF2, Raf1 and RIP1 to augment NF-κB 
activation (Kataoka and Tschopp, 2004; Koenig et al., 2014). CYLD is a de-ubquitinating 
enzyme that negatively regulates NF-κB signaling by cleaving K63 polyubiquitin chains from 
RIP1, TAK1, TRAF2 and NEMO (Christofferson et al., 2014).  Active caspase-8 is able to cleave 
CYLD at a conserved site, Asp215, and mutation of this caspase-8 cleavage site on CYLD 
promotes necroptosis instead of NF-κB activation (O’Donnell et al., 2011). Meanwhile, our 
results indicate that the IκB degradation pattern is similar between RIP1-/- and RIP3-/-caspase-8-/- 
macrophages (Fig. 2.13C, Fig. 2.14B), and that only the later time points of IκB degradation is 
impaired in the knockout cells. This suggests that the late phase of NF-κB activation mediated by 
TRIF rather than MyD88 downstream of TLR4 is affected. Furthermore, cytokine production 
induced by the TLR2 ligand Pam3Cys was unaffected in RIP3-/-caspase-8-/- macrophages (Fig. 
2.12AB). Since TLR2 utilizes MyD88/Mal not TRIF to transduce signaling, thus, caspase-8 
might mediate NF-κB activation through cooperation with RIP1 to affect the TRIF signaling arm. 
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These potential mechanisms are not mutually exclusive, but thorough investigations into the 
detailed mechanism of caspase-8-mediated NF-κB activation are still required. 
 
Inflammasome and caspase-1 activation 
This work also reveals a striking role of caspase-8 and RIP1 to mediate the processing of caspase-
1. The cleavage of caspase-1, which is normally induced by inflammasome activation, is 
completely blocked in RIP1-/- fetal liver macrophages and RIP3-/-caspase-8-/- BMDMs during Y. 
pestis infection (Fig. 2.16CD). Active caspase-1 is responsible for the maturation and secretion of 
IL-1β and IL-18. Accordingly, we also observed that IL-1β and IL-18 production induced by Y. 
pestis was significantly reduced in vitro and in vivo when caspase-8 and RIP3 are deficient (Fig. 
2.15AB, Fig. 2.18CD). We cannot currently exclude the possibility that caspase-8 also directly 
cleaves pro-IL-1β independent of caspase-1, as suggested for TLR ligands (Maelfait et al., 2008), 
Fas ligand (Bossaller et al., 2012), fungi and mycobacteria sensed by dectin-1 (Gringhuis et al., 
2012). However, our western blot results suggest that caspase-8 mediates the processing of 
caspase-1 to regulate the maturation of IL-1β cytokine (Fig. 2.16). This phenotype has also been 
observed in RIP3-/-caspase-8-/- BMDMs treated with the endoplasmic reticulum (ER) stress-
inducing drugs plus LPS (Shenderov et al., 2014). Both caspase-1 cleavage and IL-1β release 
induced by Salmonella or Pam3Cys plus nigericin are not affected in RIP3-/-caspase-8-/- or RIP1-/- 
macrophages, suggesting that these knockout cells preserve the capability to undergo 
inflammasome activation and RIP1 and caspase-8 are not universally required for caspase-1 
processing or IL-1β release. The underlying mechanism of RIP1 and caspase-8-mediated caspase-
1 processing is unknown. Our results implicate that TLR4-TRIF axis, which may participate to 
act upstream of caspase-8, is not absolutely required (Fig. 2.17DE).  Similarly, TLR4 and TRIF 
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are required for caspase-8-mediated caspase-1 cleavage and IL-1β production induced by LPS 
stimulation in the context of ER stress (Shenderov et al., 2014). Philip et al. reconstituted 
immortalized RIP3-/-caspase-8-/- macrophages with either WT caspase-8 or mutant caspase-8 
lacking the three critical aspartate residues required for auto-processing (D3A Caspase-8) and 
demonstrated that WT caspase-8 but not the D3A caspase-8 reconstitution restored Y. 
pseudotuberculosis-induced caspase-1 cleavage (Fig. 2G of Philip et al., 2014). The D3A 
caspase-8 mutant is not only uncleavable, but also lacks catalytic activity, suggesting that the 
caspase-1 processing ability of caspase-8 may be attributed to its enzymatic activity (Philip et al., 
2014). This is consistent with our result that the caspase-8 enzymatic inhibitor, IETD, blocks the 
cleavage of caspase-1 induced by Y. pestis (Fig 2.16A). Additionally, the depletion or genetic 
deficiency of cIAPs not only induces cell death via the formation of ripoptosome as discussed 
earlier in this chapter, but also triggers IL-1β release via NLRP3-caspase-1- or caspase-8-
dependent pathways (Vince et al., 2012). As previously shown, Y. pestis is able to induce cIAP 
degradation (Fig. 2.11C), which may cause the caspase-8 activation and thereby mediate caspase-
1 processing and IL-1β release.  
 
In contrast, caspase-8 has also been shown to block RIP1-RIP3-mediated NLRP3 inflammasome 
activation by LPS in dendritic cells (Kang et al., 2013).  LPS alone induces high IL-1β production 
in caspase-8 deficient but not WT dendritic cells, through inducing RIP1-RIP3-dependent 
NLRP3-ASC inflammasome assembly (Kang et al., 2013). It is uncertain whether caspase-8 
inhibits RIP1-RIP3-facilitated inflammasome activation through directly targeting the 
inflammasome components, or the deletion of caspase-8 disturbs the cellular homeostasis and 
thereby indirectly initiates the activation of inflammasome. These studies suggest that caspase-8 
represents both stimulatory and inhibitory roles to regulate inflammasome activation and IL-1β 
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production, depending on stimuli and context. Multiple mechanisms might contribute to the 
complicated role of caspases-8 in regulation of the inflammasome activation.  
 
Our results also suggest that ASC is involved in caspase-8-mediated caspase-1 processing, as 
caspase-1 cleavage is absent in ASC-/- BMDMs (Fig. 2.17F, Zheng et al., 2011). IL-1β production 
induced by Y. pestis is also significantly reduced in ASC-/- macrophages (Vladimer et al., 2012; 
Zheng et al., 2011). Salmonella or Francisella tularensis infection is able to induce the 
recruitment of caspase-8 to ASC containing specks (Man et al., 2013; Pierini et al., 2012). 
Moreover, caspase-8 has been shown to directly interact with ASC through binding to the pyrin 
domain of ASC (Pierini et al., 2012; Sagulenko et al., 2013), further suggesting that ASC might 
contribute to caspase-8-mediated caspase-1 cleavage. However, the role of ASC in caspase-8-
mediated caspase-1 processing and IL-1β maturation is still debated. Philip et al. observed the 
caspase-1 cleavage induced by Y. pseudotuberculosis YopJ is independent of ASC. Shenderov et 
al. also indicates that ASC is dispensable for caspase-8-mediated IL-1β maturation induced by 
ER stress plus LPS. The reason for this discrepancy of the role of ASC in Yersinia infection is not 
clear, but may be due to the different activities of YopJ in Y. pestis compared to Y. 
pseudotuberculosis or the different infection conditions.   
 
The role of caspase-8 and RIP kinases during in vivo Y. pestis infection  
Our in vitro work indicates that caspase-8 and RIP kinases play critical roles in Y. pestis-induced 
cell death and innate immune responses, including caspase-1 processing, IL-1β maturation and 
optimal NF-κB activation, all of which are important to counteract pathogen infection. To expand 
these results in vivo, we utilized a mouse model of plague. RIP3-/-caspase-8-/- mice quickly 
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succumbed to subcutaneous infection with Y. pestis, indicating that caspase-8 and RIP3 are key 
factors to counteract bubonic plague (Fig. 2.18B). In agreement with our in vitro results, the death 
of splenic myeloid cells and the release of cytokines including IL-1β, IL-18, IL-6 and TNFα are 
significantly reduced in the infected RIP3-/-caspase-8-/- mice compared to the WT control. As 
causative agent of plague, Y. pestis induces three different forms of diseases via different 
infection routes, bubonic, septicemic and pneumonic plague (see Chapter I). It will be interesting 
to investigate whether caspase-8 and RIP3 also play protective roles in the model of pneumonic 
plague similar to the bubonic disease. Similar to our results, Philip et al. also showed that mice 
lacking caspase-8 and RIP3 in the hematopoietic compartment are susceptible to oral infection by 
Y. pseudotuberculosis (Philip et al., 2014), which broadens the role of caspase-8 and RIP3 to fight 
off infection with other human pathogenic Yersinia strains.   
 
RIP1 demonstrates similar functions as caspase-8 during in vitro Yersinia infection. Presumably, 
the role of RIP1 in vivo should be similar as caspase-8 as well. Although RIP1-/- mice are not 
embryonically lethal, they die shortly after birth, making it difficult to directly test the phenotype 
of RIP1 deficient mice by Yersinia infection (Kelliher et al., 1998). However, our results indicate 
that RIP1 kinase activity is important to regulate Yersinia-induced cell death and caspase-1 
processing, which were inhibited by specific RIP1 kinase inhibitor GSK’963 or Nec-1 (Philip et 
al., 2014). Very recently, several groups have successfully generated RIP1 kinase-dead mice with 
either a D138N mutation or a K45A mutation (Berger et al., 2014; Kaiser et al., 2014; Newton et 
al., 2014). All of these mutant mice are healthy and viable. It will be very interesting and 
informative to infect these RIP1 kinase-dead mice with Y. pestis and investigate the in vivo role of 
RIP1 kinase activity. 
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As described in Chapter I, the contribution of YopJ to the virulence of Y. pestis is still 
controversial. In vitro, YopJ acts as a serine/threonine acetyltransferase, and harbors multiple 
activities, such as inhibiting NF-κB and MAPK pathways, inducing rapid apoptotic cell death, 
and triggering inflammasome activation. Despite these robust effects in vitro, YopJ does not have 
an equivalent effect in vivo. The deletion of YopJ fails to affect the virulence of Y. pestis via the 
subcutaneous infection route (Lemaître et al., 2006). The reason why YopJ exhibits such different 
effects in vitro and in vivo is unknown. One possible explanation is that during the disease 
progression, pathways effected by YopJ counteract each other and therefore the virulence 
outcome is not significantly influenced. Although YopJ can inhibit NF-κB and MAPK activation 
and dampen the production of pro-inflammatory cytokines like IL-6 and TNFα, it is able to 
induce inflammasome activation and prompt the release of IL-1β and IL-18. Therefore, the 
reduced innate immune effect by decreased IL-6 and TNFα is compensated by the pro-
inflammatory effect of IL-1β and IL-18.  Meanwhile, cell death induced by YopJ will also trigger 
inflammation. The RIP3-/-caspase-8-/- mice or RIP1 kinase-dead mice can be used to dissect the 
different effects of YopJ in vivo, as the cell death and caspase-1 activation induced by YopJ are 
inhibited in these mutant mice. Through infecting RIP3-/-caspase-8-/- mice with WT or ΔYopJ Y. 
pestis, or infecting WT and RIP3-/-caspase-8-/- mice with Y. pestis ΔYopJ strain, more knowledge 
will be gained regarding the virulence regulation by YopJ. 
 
Conclusion 
Y. pestis is well known as an expert pathogen to evade innate immune surveillance to cause 
plague. Upon infection, Y. pestis can replicate quickly in the host to reach extraordinary densities 
in the blood and tissues, up to 108 CFU per milliliter. Disease progresses fast and the patients 
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succumb to infection before developing an effective adaptive immune response to fight the 
bacteria. Hence, the innate immune responses are critical to control Y. pestis infection, enabling Y. 
petsis to be an ideal model to study the role of innate immune components in bacterial infection. 
To counteract or escape the recognition by the innate immune system of mammalian host, Y. 
pestis has evolved with different virulence factors, including type three secretion system (T3SS), 
non-stimulatory LPS at 37°C and so on. Producing non-stimulatory LPS enables the bacteria not 
recognized by TLR4/MD2; while the T3SS-injected Yop effectors interrupt intracellular signaling 
pathways, including the inhibition of NF-κB pathway and induction of cell death by YopJ. Our 
work implies that effects by these virulence factors converge on the axis of RIP1-caspase-8-RIP3 
in the host immune cells. Caspase-8 and RIP kinases not only mediate YopJ-dependent cell death, 
but also regulate the optimal production of pro-inflammatory cytokines like IL-6 and TNFα via 
NF-κB. Last but not least, RIP1 and caspase-8 are involved in caspase-1 activation, leading to the 
maturation of IL-1β and IL-18. All these contributions determine the importance of caspase-8 and 
RIP kinases to combat against bacterial infection in vivo. In addition to the well-known pattern 
recognition receptors, our work strongly suggests that caspase-8 and RIP kinases are critical 
innate immune components to control bacterial infection. It will be interesting and rewarding to 
investigate the role of caspase-8 and RIP kinases during infection with other pathogens. The 
novel roles unveiled in this thesis work not only help broaden our understanding about caspase-8 
and RIP kinases, but also provide new insight into designing therapies to treat Yersiniae 
infections. 
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